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 i 
ABSTRACT 
 
 Accumulation of excess white adipose tissue in obesity has detrimental consequences 
for metabolic health. Activation of thermogenic adipocytes confers beneficial efects on 
metabolic health and is considered a potential therapeutic target for human obesity. 
Hormones modulating adaptive thermogenesis include melanocortins and pituitary adenylate 
cyclase-activating polypeptide (PACAP). In PACAP -/- mice, metabolism and thermogenic 
capacity in response to cold is impaired. I hypothesized PACAP acts in the ventromedial 
nucleus of the hypothalamus, upstream of the melanocortin system, to regulate sympathetic 
stimulation of thermogenesis. To assess this, PACAP +/+ and PACAP -/- mice were cold 
acclimated to 4°C and given daily injections of a melanocortin receptor agonist, Melanotan I 
(MTI), for 24 days. The efect of MTI on thermogenesis was examined by physiological, 
molecular, and histological analyses. Results show MTI partialy rescued the impaired 
thermogenic capacity in PACAP -/- mice as compared to PACAP +/+ mice, providing 
evidence to support our hypothesis. 
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CHAPTER 1 
Endocrine Physiology of Obesity: Energy Homeostasis and Thermogenesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
1.1 OBESITY AS A DISEASE 
Obesity is a disease characterized by increased white adipose tissue (WAT) mass 
resulting from both adipocyte hyperplasia and celular hypertrophy (Galic, Oakhil, & 
Steinberg, 2010; Lee, & Shao, 2014). With chronic food abundance and the change to 
sedentary work practices and lifestyles in modern society, the prevalence of adult obesity has 
more than doubled worldwide since 1980 (Finucane et al., 2011). In 2014, it was estimated 
that 39% of the world’s adult population was overweight, defined by the World Health 
Organization (WHO) as a person with a body mass index (BMI) (body mass (kg)/height 
(m)2) greater than or equal to 25 (Lee, & Shao, 2014; WHO, 2016; Yeo, & Heisler, 2012). 
Overweight and obesity afects al age and socioeconomic groups and poses a substantial 
economic burden on society and health care systems due to increased risk of developing 
chronic disease such as cardiovascular disease, type 2 diabetes, arthritis, hypertension, stroke, 
and some forms of cancer (Lidel, Betz, & Enerbäck, 2014; WHO, 2016). In addition, while 
the prevalence of obesity continues to rise, so too does the stigma (Lidel et al., 2014). 
Negative stereotypes that persons with obesity are lazy, lacking self-discipline, or 
unmotivated may translate into inequalities in health care, education and employment 
(Canadian Obesity Network, 2016). Research has shown that body weight is determined by 
both environmental and genetic factors. Geneticaly, body weight is a polygenic factor, 
similar to height, skin, eye, and hair color, indicating that the development of obesity is 
influenced by more than a person’s motivation, self-control, and lifestyle (Hinney, Vogel, & 
Hebebrand, 2010). A person’s genetic predisposition to the disease can result from 
pathophysiological changes that lead to increased eficiency in energy metabolism and a state 
of chronic positive energy balance (Choquet, & Meyre, 2011; Waley, 2006). The 
consequences of overweight and obesity range from decreased overal quality of life to 
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premature death; indicating the necessity to understand the causes of obesity such that it can 
be prevented and treated efectively (Centre for Disease Control, 2016; Galic et al., 2010; 
WHO, 2016). 
1.2 CAUSES OF OBESITY 
Obesity is determined by both genetic makeup and environmental factors (Farooqi & 
O’Rahily, 2006; Hinney, Vogel, & Hebebrand, 2010). The cause of obesity can be explained 
by a homeostatic imbalance in energy metabolism and impaired adipose tissue function 
(Harwood, 2012). Metabolic homeostasis is achieved when energy intake matches energy 
output. Energy intake consists of food consumption while energy expenditure includes basal 
metabolic rate, waste production, physical activity, and thermogenesis (Figure 1.1), which 
wil be a major focus of the research in Chapters 2 and 3 and discussed in detail below. 
When energy intake chronicaly exceeds energy expenditure, adipose tissue expands 
both in mass and size due to an increase in the number of cels and the size of the adipocytes, 
which increase as triglycerides accumulate within (Fonseca-Alaniz, Takada, Alonso-Vale, & 
Lima, 2007; Harwood, 2012). Research has shown that adipose tissue itself plays an 
important role in the maintenance of metabolic homeostasis. In obesity, WAT is 
dysfunctional with a change in the production of adipocyte-derived factors including 
adipokines (discussed below), free faty acids (FFAs), and cytokines that control metabolic 
homeostasis of a variety of tissues on a molecular level (Greenberg, & Obin, 2006; Lee, & 
Shao, 2014). It is this dysfunctional WAT that is found to be associated with an increased 
risk for the chronic diseases listed above in obesity (Lee, & Shao, 2014). Thus, research into 
the biological mechanisms linking adipocyte function with energy homeostasis wil shed 
light on the biological complexities of obesity and may lead to innovative therapeutic  
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Figure 1.1. Factors contributing to the energy balance equation. 
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treatments for this disease. Further evidence for a key role of adipose tissue in the 
maintenance of energy homeostasis wil be discussed here. 
1.3 WHITE ADIPOSE TISSUE AS A STORAGE AND ENDOCRINE ORGAN 
WAT is comprised predominantly of white adipocytes; a cel type specialized in 
storing energy as triglycerides. WAT also contains macrophages, fibroblasts, and 
preadipocytes held together by loose connective tissue and is highly vascularized and 
innervated by the autonomic nervous system (Ahima, 2006). It acts as a thermal insulator by 
reducing heat loss through the skin, and as a protective layer around organs and muscle 
groups where it softens impact to ensure proper functioning of these tissues without the loss 
of integrity (Harwood, 2012).  
WAT has long been known for its role as an energy reservoir, involved in both lipid 
and glucose metabolism. In periods of caloric abundance, consumed glucose and lipids 
stimulate insulin release from the pancreas, which promotes uptake of FFAs in the liver and 
WAT where they are combined with glycerol to form triglycerides (Galic et al., 2010). 
Additionaly, excess glucose is stored as triglycerides in the liver and WAT through the 
process of lipogenesis (Galic et al., 2010). During energy shortage or periods of fasting, 
insulin levels fal and stimulate lipolysis in WAT, resulting in glycerol and FFAs that supply 
gluconeogenic and oxidative pathways in the liver where glycogen breakdown occurs to 
increase circulating glucose levels, therefore supplying the brain and vital organs with energy 
(Galic et al., 2010; Harwood, 2012; Lee, & Shao, 2014; Vázquez-Vela, Tores, & Tovar, 
2008).  
Gavrilova et al. (2000) demonstrated the critical importance of white adipose tissue in 
metabolic homeostasis with their mouse model of lipoatrophic diabetes, known as the A-
ZIP/F-1 mouse line. The mouse line was generated by targeting an adipocyte-specific 
 6 
transgene that expresses a dominant-negative protein, known as A-ZIP/F, resulting in the 
inhibition of adipocyte-specific proteins and DNA binding (Moitra et al., 1998). The result 
was mice that had virtualy no WAT. The mice developed characteristics similar to those of 
humans with severe lipoatrophic diabetes, including insulin resistance, hyperglycemia, 
hyperlipidemia, and faty livers. Transplantation of healthy WAT into the A-ZIP/F-1 mice 
reversed the phenotype, and resulted in normoglycemic mice with lowered insulin levels, 
decreased serum triacylglycerols, decreased hepatic gluconeogenesis, and decreased amounts 
of fat deposited in the liver. These beneficial efects were dependent on the presence of 
transplanted WAT and thus it became evident that the lack of WAT is metabolicaly 
detrimental (Gavrilova et al., 2000). These results provided a compeling platform for the 
argument that adipose tissue plays an important role in maintaining homeostasis on a 
molecular level, as suggested above. In fact, research has shown that WAT efectively 
communicates with the body and brain through the secretion of greater than 50 adipocyte-
specific factors that include hormones and cytokines (Figure 1.2) (Galic et al., 2010; 
Harwood, 2012; Lee, & Shao, 2014; Sakurai et al., 2013). These adipocyte-specific factors, 
known as adipokines, act on both central and peripheral organs such as the liver, pancreas, 
brain, and skeletal muscle to control diverse metabolic processes including energy 
expenditure, lipid metabolism, food intake, and inflammation (Harwood, 2012). The 
discovery of adipokines led to the now widely accepted and recognized role of WAT as a 
major endocrine organ, in contrast to its early classification as a passive, metabolicaly 
inactive organ that simply acted as a storage reservoir for energy (Galic et al., 2010; 
Greenberg, & Obin, 2006; Harwood, 2012; Lee, & Shao, 2014; Trayhurn, 2005; Vázquez-
Vela et al., 2008). In the majority of cases of overweight or obesity, adipose tissue is 
characterized by profound histological and biochemical changes associated with  
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Figure 1.2. Key adipokines and adipo-cytokines secreted by white adipose tissue. TNF-α, tumor 
necrosis factor-α; MCP-1, monocyte chemoatractant protein-1; IL-6, interleukin-6; PAI-1, 
plasminogen activator inhibitor-1. Reprinted from “The Effects of Exercise Training on Obesity-
Induced Dysregulated Expression of Adipokines in White Adipose Tissue”, by T. Sakurai, J. 
Ogasawara, T. Kizaki, S. Sato, Y. Ishibashi, M. Takahashi et al., 2013, International Journal Of 
Endocrinology, 1-28. Copyright © 2013 Takuya Sakurai et al. Reprinted with permission from 
author. 
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dysregulation of adipokine secretion, lipotoxicity, and inflammation; al of which contribute 
to metabolic dysfunction (Ahima, 2006; Greenberg, & Obin, 2006). Although not directly 
part of the research in this thesis, the metabolic function of one of the most wel studied 
adipokines, leptin, wil be discussed here for further background. Of particular interest wil 
be leptin’s action on one of the systems of interest for this thesis; the melanocortin system, 
discussed in detail below. 
1.4 LEPTIN: A KEY REGULATOR IN ENERGY HOMEOSTASIS  
Leptin, the first adipocyte hormone to be identified, is produced mainly by adipocytes 
and crosses the blood-brain barier to bind leptin receptors in the hypothalamus (Yeo, & 
Heisler, 2012). Leptin is also produced at low levels by the stomach, placenta, bone, skeletal 
muscle, and other tissues, although the target in these cases is likely to be local and therefore 
paracrine in action rather than endocrine (Trayhurn, 2005). Zhang et al. (1994) first identified 
leptin while studying obese mice with a naturaly occuring genetic mutation in the ob gene 
(ob/ob). Without the ob gene, which was found to code for leptin (named by Halaas et al. in 
1995), the mice were morbidly obese and diabetic due to severe hyperphagia and decreased 
energy expenditure. When treated with regular injections of leptin into the brain, the ob/ob 
mice reduced their food intake, increased their metabolic rate, and lost weight (Greenberg, & 
Obin, 2006). Although analogous genetic mutations in humans are extremely rare, the 
clinical presentation of patients with genetic mutations in the leptin gene or its receptor is 
very similar to the phenotype of the ob/ob mice and leptin therapy is beneficial in these cases 
(Farooqi, & O’Rahily, 2006). These seminal findings exhibited the importance of leptin as a 
key regulator of energy balance, and introduced the idea that adipose tissue was an important 
endocrine organ involved in regulating whole body energy metabolism. Classic pathways of 
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leptin action in the brain and its efects on feeding behavior have been wel elucidated and 
the best-described pathways are depicted in Figure 1.3. 
Briefly, leptin acts on the melanocortin axis (discussed in detail below), positively 
regulating neurons within the arcuate nucleus (ARC) that express pro-opiomelanocortin 
(POMC) and cocaine- and-amphetamine regulated transcripts (CART). POMC then 
undergoes post-translational modification and is processed into alpha melanocyte-stimulating 
hormone (α-MSH), which then binds melanocortin 4 receptors (MC4R) to inhibit food intake 
(How, 2016; Yeo, & Heisler, 2012). Furthermore, leptin negatively regulates the MC4R 
antagonist agouti-related protein (AGRP) and neuropeptide Y (NPY) whose normal functions 
are to increase food intake, therefore further inhibiting food intake (How, 2016; Tabeta, & 
Beutler, 2012). Although leptin’s role in appetite regulation through the modulation of the 
melanocortin system in the ARC has been extensively studied, it is apparent that the ARC 
cannot explain al aspects of leptin function (Bingham et al., 2008). For example, when leptin 
receptors were specificaly deleted in POMC neurons, mouse body weights increased to only 
18% of that observed in mice with complete lack of leptin receptors (Balthasar et al., 2004). 
This suggests that leptin acts elsewhere to control energy homeostasis, and that its function in 
other brain regions should be considered (Balthasar et al., 2004). As such, leptin has been 
shown to enhance energy expenditure by increasing thermogenesis, faty acid (FA) oxidation, 
and plasma glucose levels (Havel, 2002). Acting in the ventromedial hypothalamus (VMN), 
leptin increases sympathetic nerve activity by means of the melanocortin system, resulting in 
activated thermogenesis (further discussed in Chapter 3) (Butler, & Cone, 2002; Hwa et al., 
1996; Satoh et al., 1999; Scarpace, Matheny, Polock, & Tumer, 1997; Voss-Andreae et al., 
2007). Importantly, this mechanism wil be further discussed throughout this thesis. Other  
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Figure 1.3. Pathways mediating leptin action in the arcuate nucleus for its role in appetite regulation. 
Ilustration by D. La Vine. MUTAGENETIX ™, B. Beutler and coleagues, 2012, Center for the 
Genetics of Host Defense, UT Southwestern, Dalas, TX. Copyright © LabArchives, LLC. Reprinted 
with permission from author. 
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functions of leptin include acting as a major signal to the reproductive system and as a factor 
in the immune system (Flier, 2004; Havel, 2002; Trayhurn, & Beatie, 2001). 
Circulating leptin levels increase linearly with weight gain and decrease with weight 
loss or during fasting, proportional to adipose tissue mass. In healthy humans, leptin 
production is stimulated by adipocyte glucose metabolism in the postprandial state to reduce 
feeding behavior (Fonseca-Alaniz et al., 2007; Mueler et al., 1998). During fasting, both 
leptin and insulin decrease which stimulates appetite, inhibits sympathetic nerve activity, 
inhibits thermogenesis and suppresses the action of reproductive hormones, growth hormones 
and thyroid hormones (Ahima, 2006; Harwood, 2012). Whereas decreases in leptin inhibit 
food intake and food seeking behaviors, increases in leptin associated with overfeeding or 
obesity appear to have substantialy less of a biological impact (Havel, 2002). For example, 
administering leptin to obese humans without leptin deficiency induces variable, modest, or 
no weight loss (Havel, 2002). Despite having high levels of leptin, which intuitively should 
reduce food intake and body fat, people with obesity maintain high levels of adipose tissue 
(Galic et al., 2010). The proposed reasoning for this phenomenon is leptin resistance, 
particularly in metabolicaly active tissues such as skeletal muscle (Westerterp-Platenga, 
Saris, Huckshorn, & Campfield, 2001). Therefore, the major role of leptin appears not to be 
as a restraint to limit energy intake and obesity, but rather an endocrine factor that alowed 
physiological adaptation to reduced energy intake in times of decreased nutrient availability 
and reduced body fat stores (Havel, 2002). Whether leptin resistance is the cause or 
consequence of obesity is yet to be identified, and while the metabolic efects of leptin on 
target tissues are robust, the precise mechanism by which it is secreted from the adipocyte 
remains elusive (Ahima, 2006; Stern, Rutkowski, & Scherer, 2016). Further investigation 
into the developmental origins and biological mechanisms of leptin is pertinent for potential 
 12 
therapeutic targeting (Peirce, Carobbio, & Vidal-Puig, 2014; Stern et al., 2016). As 
mentioned above, however, one of the key mediators of leptin action is the melanocortin 
system, which wil be discussed here (Butler, & Cone, 2002; Voss-Andreae et al., 2007). 
1.5 THE CENTRAL MELANOCORTIN SYSTEM IN ENERGY HOMEOSTASIS  
The central pathways mediating the melanocortin system’s role in energy homeostasis 
is wel characterized (Cone, 1999; Cone, 2005; Elacot, & Cone, 2006). It detects and 
integrates a variety of neuronal, hormonal, and nutritional metabolic signals such as leptin 
(discussed above), insulin, glucose, and serotonin to influence energy metabolism (Jeong, 
Kim, & Lee, 2014). Melanocortins, such as α-MSH and β-endorphin, are a family of smal 
peptides that originate from the POMC precursor (Figure 1.4) (Bowen, 2006). 
Greenman et al. (2013) showed that mice with postnatal ablation of POMC neurons in 
the ARC in the hypothalamus resulted in an obese phenotype with reduced energy 
expenditure, similar to that observed in leptin-deficient animal models. POMC gene deletion 
and gene mutations have also shown to be highly corelated with obesity development in 
humans (Dubern et al., 2008; Chalis et al., 2004; Krude et al., 1999; Yaswen, Diehl, 
Brennan, & Hochgeschwender, 1999). Additionaly, when POMC is overexpressed in the 
ARC either by virus-associated gene delivery or genetic modification in leptin deficient 
animals, they were protected from the development of obesity (Li, Mobbs, & Scarpace, 2003; 
Mizuno, Kely, Pasineti, Roberts, & Mobbs, 2003). These studies demonstrate a clear role of 
the central POMC system in metabolic regulation. 
Melanocortin receptor expression and function in the mammalian brain have been 
wel elucidated since the 1990’s (Cone, 1999; Jeong, Kim, & Lee, 2014). In geneticaly 
altered animals lacking the gene for melanocortin receptor types 3 and 4 (MC3R and MC4R, 
respectively), an obese phenotype ensues, providing evidence for the involvement of  
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Figure 1.4. Multiple peptides produced from the single pro-protein, proopiomelanocortin (POMC). 
Ilustration by R. Bowen, 2006, Colorado State University. Obtained from 
htp:/www.vivo.colostate.edu/hbooks/pathphys/endocrine/hypopit/acth.html. Reprinted with 
permission from author. 
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melanocortins in the regulation of energy metabolism (Cone, 1999). MC3Rs and MC4Rs are 
found in several brain regions in the hypothalamus known for the regulation of energy intake 
processes such as feeding, and energy output processes such as thermogenesis, including the 
paraventricular nucleus (PVN), the arcuate nucleus (ARC) (discussed earlier in terms of 
leptin regulation), the ventromedial nucleus (VMN) (the brain region of interest for Chapter 
3), the lateral hypothalamic area (LHA), and dorsomedial nucleus (DMN) (Figure 1.5) 
(Cone, 1999). The research presented in this thesis relates to the melanocortin system’s role 
in energy output through the activation of thermogenesis in brown adipose tissue (BAT). 
1.6 BROWN ADIPOSE TISSUE AS A POTENTIAL THERAPEUTIC TARGET FOR 
OBESITY  
Brown adipose tissue (BAT) has been wel characterized in rodents and other smal 
mammals (Haney et al., 2002). In humans, BAT was thought to exist predominantly in the 
interscapular region in infants only and was rapidly lost postnataly such that only vestigial 
amounts remained later in life (Haney et al., 2002; Nedergaard, Bengtsson, & Cannon, 2007). 
In 2007, however, it was shown that brown adipocytes reside in the cervical and 
supraclavicular regions in human adults (Bartelt, & Heeren, 2013; Haney et al., 2002). 
Similar to WAT, BAT is capable of accumulating and storing lipids. However, BAT is 
distinct from WAT in that its adipocytes contain an abundance of mitochondria (Figure 1.6) 
that are enriched with a specialized protein caled uncoupling protein 1 (UCP1), which 
uncouples substrate oxidation from adenosine triphosphate (ATP) production such that heat 
is produced (Lidel et al., 2014; Peirce et al., 2014). This process of heat production is the 
major role of BAT and is known as adaptive thermogenesis (discussed below).  
Interestingly, as a result of thermogenic stimuli, brown-like adipocytes are observed 
in some WAT regions: a process known as “browning” of WAT (Bartelt, & Heeren, 2013). 
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Figure 1.5. Coronal cross section of the brain showing the location of the hypothalamus and close-up 
five key hypothalamic nuclei involved in the regulation of energy metabolism. PVN; paraventricular 
nucleus, DMN; dorsomedial nucleus, LHA; lateral hypothalamic area, VMN; ventromedial nucleus, 
ARC; arcuate nucleus, 3V; third ventricle. Adapted from “Revisiting the Ventral Medial Nucleus of 
the Hypothalamus: The Roles of SF-1 Neurons in Energy Homeostasis”, by Y. Choi, T. Fujikawa, J. 
Lee, A. Reuter, & K. Kim, 2013, Frontiers In Neuroscience, 7. Copyright © 2013 Choi, Fujikawa, 
Lee, Reuter and Kim. Adapted with permission from author. 
 
 
Figure 1.6. Histological representation differentiating WAT and BAT. WAT is unilocular with large 
lipid droplets (imaged at 40x), while BAT contains multilocular lipid droplets with a characteristic 
abundance of mitochondria (imaged at 60x using oil immersion). Images from studies in the Gray lab. 
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Although these adipocytes are capable of undergoing adaptive thermogenesis, their lineage is 
closer to that of white adipocytes than brown adipocytes (Bartelt, & Heeren, 2013; Giralt, & 
Vilaroya, 2013). These adipocytes are refered to as beige, brite (brown in white), or 
inducible adipocytes (Giralt, & Vilaroya, 2013). For the remainder of this thesis, they wil be 
refered to as beige adipocytes. Although the activation of BAT and the browning process in 
WAT share common pathways of induction the focus here wil be on brown adipocytes and 
BAT, while acknowledging that other thermogenic adipocytes exist and are curently under 
intense study (Giralt, & Vilaroya, 2013). The relevance of BAT wil be discussed in terms of 
energy metabolism, as evidence suggests that obesity may in part be determined by reduced 
energy expenditure (Flier, 2004).  
1.7 THERMOGENESIS IN BROWN ADIPOSE TISSUE 
Thermoefector mechanisms exist for both heat and cold defense. These include 
thermoregulatory behaviors to increase or decrease the amount of heat loss, cutaneous 
vasodilation or constriction, evaporative cooling (sweating) or heat production 
(thermogenesis) (Morison, 2016). Thermogenesis, a component of the ‘energy out’ aspect of 
the energy balance equation (total body energy = energy in – energy out), is the behavioral 
and autonomic increase in body temperature in response to cold stress or overfeeding to 
preserve energy homeostasis (Morison, 2016). Upon cold stimulation in rodents and human 
adults, thermogenesis is initialy mediated by shivering in skeletal muscle that produces heat 
through mechanical work (Morison, 2016). After prolonged cold stimulation, shivering 
subsides while non-shivering, or adaptive thermogenesis increases in brown (and beige) 
adipocytes that are activated by eferent signals from the hypothalamus via sympathetic 
nerve innervation (Figure 1.7) (Blondin et al., 2014; Lidel et al., 2014; Peirce et al., 2014). 
The sympathetic neural input promotes mitochondria oxidation that shunts proton fluxes into 
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Figure 1.7. Cold-induced activation of adaptive thermogenesis in brown adipose tissue. UCP1; 
uncoupling protein 1. Adapted from “Activation and recruitment of brown adipose tissue by cold 
exposure and food ingredients in humans”, by M. Saito, T. Yoneshiro, & M. Matsushita, 2016, Best 
Practice & Research Clinical Endocrinology & Metabolism, 30(4), 537-547. Copyright © 2017 
Elsevier B.V. Adapted with permission from publisher.�
 
 
 
 
 
 
 
 
 
 
 
 
 
(See Figure 1.8 for mechanism) 
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heat production via the specialized protein UCP1 (Figure 1.7). The unique capacity to 
undergo the energeticaly expensive process of adaptive thermogenesis has brought BAT into 
the limelight as a potential therapeutic target in pathological states of energy dysfunction, 
including obesity (Chechi, Carpentier, & Richard, 2013; Lidel et al., 2014; Saito, 2013).  
Norepinephrine (NE) released by the postganglionic sympathetic neurons is the 
primary neurotransmiter that activates thermogenesis in brown adipocytes in response to 
cold (Chechi et al., 2013; Lidel et al., 2014; Hawke et al., 2009). NE binds to the β3-
adrenergic G protein-coupled receptors (GPCRs), which activates the G protein alpha-subunit 
and phosphorylates adenylate cyclase (Figure 1.8). This enzyme converts ATP to cyclic 
adenosine monophosphate (cAMP) that activates protein kinase A (PKA). PKA acts on 
downstream messenger proteins such as hormone-sensitive lipase (HSL), which induces 
lipolysis that generates FFA’s, serving two roles: activating UCP1 which is only found on the 
inner mitochondrial membrane of brown adipocytes, and undergoing FA catabolism via β-
oxidation to fuel thermogenesis (Chechi et al., 2013; Lidel et al., 2014; Hawke et al., 2009). 
Activated UCP1 uncouples oxidative phosphorylation from ATP generation by bypassing 
ATP synthase and enabling the reflux of protons across the inner mitochondrial membrane 
down the proton gradient. It is this proton leak, or disruption of the proton gradient, that 
generates heat and results in whole-body energy expenditure (Chondronikola et al., 2016; 
Lidel et al., 2014).  
 Evidence for the role of BAT in energy expenditure has been shown experimentaly 
in animal and human models. When BAT is ablated geneticaly in mice, obesity ensues 
(Lowel et al., 1993). However, when BAT is regenerated in these transgenic mice, obesity 
resolves (Lowel et al., 1993). Genetic overexpression of UCP1 in mice has also been shown 
to mitigate obesity induced by a high-fat diet, providing evidence that enhancing thermogenic 
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Figure 1.8. Molecular mechanisms of adaptive thermogenesis at the level of brown adipocytes. 
Adapted from Wikipedia, 2009. Obtained from htps:/en.wikipedia.org/wiki/Thermogenesis. 
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potential via increased UCP1 activity is able to alter body weight in mice and thus elicits 
potential as a therapy to regulate body weight in humans (Kopecky et al., 1995). Mice 
lacking UCP1 fail to demonstrate an obesogenic efect at room temperature (23°C), yet in 
thermoneutrality (30°C; the optimal temperature at which normal body temperature can be 
maintained for mice), obesity develops (Enerbäck et al., 1997; Feldmann, Golozoubova, 
Cannon, & Nedergaard, 2009). These results can be explained by the demand for the mice to 
compensate with shivering at colder temperatures and demonstrates that ambient temperature 
is a determinant for metabolic studies. 
Just as WAT can undergo adaptive and dynamic changes during periods of prolonged 
starvation or overfeeding, so too can BAT in response to cold or thermoneutrality (Bartelt, & 
Heeren, 2013). For example, both UCP1 expression and BAT mass are increased in mice 
housed at colder temperatures when compared to mice housed at thermoneutrality (Lim et al., 
2012; Yoo et al., 2014). Human studies have also demonstrated that BAT plays a 
physiologicaly significant role in thermoregulation as observed by increased BAT activity 
during mild cold exposure, and with the observation that BAT activity is highly corelated 
with BMI such that BAT activity decreases as BMI increases (Chen et al., 2013; 
Chondronikola et al., 2016; Vijgen et al., 2011). In addition, both BAT activity and mass 
decline in older individuals, which may be associated with the accumulation of body fat 
observed with aging (Pfannenberg et al., 2010; Wang et al., 2015; Yoneshiro et al., 2011). 
Precise mechanisms of BAT activation and modulation continue to be studied and necessitate 
further elucidation before BAT can be targeted for therapeutics. Increasing information on 
some of the classic hormones, proteins, endocrine factors, and pathways regulating BAT 
function are becoming known, including endocrine pathways involving thyroid hormones, 
bone morphogenetic proteins, natriuretic peptides, and the melanocortin system (discussed 
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above) (Chechi et al., 2013; Koojiman et al., 2014; Labbé et al., 2015). The Gray lab, and 
thus this research, is interested in a novel hormone deemed essential for the adaptive 
thermogenic response of BAT to cold exposure caled pituitary adenylate cyclase-activating 
polypeptide (PACAP) and wil be discussed here (Rudecki, & Gray, 2016).  
1.8 PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP): 
ESSENTIAL FOR THE THERMOGENIC RESPONSE IN BAT  
Discovered in 1989, PACAP is widely expressed in the brain and peripheral organs, 
notably in the gonads, adrenal glands, pancreas, respiratory and urogenital tracts, and 
involved in an aray of physiological functions including modulation of immune and 
inflammatory responses, dilation of vessels and bronchi, psychomotor control, the stress 
response and energy metabolism (Miyata et al., 1989; Vaudry et al., 2009; Xu et al., 2016). 
Receptors are located in the lungs, liver, testis, adrenal gland, and pancreatic islets and are 
particularly abundant in the brain, especialy in the DMN, PVN, ARC, LHA, and VMN of 
the hypothalamus (Figure 1.5) (Hashimoto et al., 1996; Nakata, Shioda, Oka, Maruyama, & 
Yada, 1999). PACAP is known for its pleiotropic biological actions and its role as a master 
stress regulator (Rudecki, & Gray, 2016). Here, the focus wil be on its role in thermogenic 
stress and energy metabolism. 
Expressed in the pancreatic nerve fibers and islets, PACAP potently augments 
glucose-induced insulin secretion by acting on pancreatic beta-cels and is thus considered a 
regulator of glucose metabolism (Nakata et al., 1999; Nakata et al., 2004). It also promotes 
feeding behavior by activating neurons in the ARC (discussed above), known as the 
hypothalamic feeding center, and induces lipolysis in WAT (Nakata, & Yada, 2007; Rudecki, 
& Gray, 2016). It has been shown that leptin signaling enhances PACAP expression in 
steroidogenic factor 1 (SF1) cels of the VMN and strong evidence suggests that PACAP 
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forms an important downstream component of the acute efects of leptin on energy balance. 
For example, PACAP mRNA levels were significantly reduced in leptin-deficient mice and 
were restored with exogenous leptin treatments (Hawke et al., 2009). Further 
neuroanatomical mapping is required to further elucidate the interactions between leptin and 
PACAP; however, proposed interactions are shown in Figure 1.9. Additional interactions 
involved in this mechanism wil be further discussed here. 
Both pharmacological and genetic evidence exists for PACAP’s essential role in 
thermogenesis. Although PACAP and its receptors are highly expressed in the PVN and the 
VMN, the VMN is known to be a region of the hypothalamus important for the regulation of 
energy homeostasis by integrating behavioral and metabolic mechanisms. Normal VMN 
functions include decreasing food intake in response to satiety and increasing energy 
expenditure, as obesity ensues with VMN lesions (Resch et al., 2011). When PACAP is 
injected directly into the VMN of healthy, wildtype mice, food intake is significantly 
reduced, core body temperature and spontaneous locomotor activity is increased, and BAT 
UCP1 mRNA expression is increased (Hawke et al., 2009; Resch et al., 2011). These efects 
were not observed when PACAP was injected into the PVN, suggesting the VMN as a major 
center for PACAP-mediated thermogenesis (Resch et al., 2011; Resch et al., 2013). Using 
PACAP-/- mice generated by Gray, Cummings, Jirik, & Sherwood (2001) the Gray lab is 
exploring PACAP’s role specificaly in the VMN in activating BAT thermogenesis and this 
wil be the focus of the research presented in Chapter 3. 
Geneticaly, without the PACAP gene, PACAP-/- mice display high mortality rates 
(89%) when raised at 21°C as compared to those raised at 24°C (24%), (Adams et al., 2008; 
Gray et al., 2001; Gray, Yamaguchi, Vencova, & Sherwood, 2002). These mice are sensitive 
to a 4°C cold chalenge, displaying reduced levels of NE and β-adrenergic receptors, and  
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Figure 1.9. Proposed pathways of neuropeptides that interact to induce adaptive thermogenesis in 
BAT in response to cold exposure. VMN; ventromedial nucleus, PACAP; pituitary adenylate cyclase-
activating polypeptide, MC; melanocortin system, SNA; sympathetic nerve activity, BAT; brown 
adipose tissue. Images adapted from “Revisiting the Ventral Medial Nucleus of the Hypothalamus: 
The Roles of SF-1 Neurons in Energy Homeostasis”, by Y. Choi, T. Fujikawa, J. Lee, A. Reuter, & 
K. Kim, 2013, Frontiers In Neuroscience, 7. Copyright © 2013 Choi, Fujikawa, Lee, Reuter and Kim. 
Adapted with permission from author. 
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impaired upregulation of UCP1 with cold exposure (Diané et al., 2014; Gray et al., 2002). 
These findings indicate PACAP’s role as a critical hormone regulator of BAT thermogenesis 
(Adams et al., 2008; Gray et al., 2001; Gray et al., 2002). 
1.9 GAP IN LITERATURE: CONNECTING PACAP AND THE MELANOCORTIN 
SYSTEM  
As stated above, the central melanocortin system plays a critical role in regulating 
energy expenditure whereby α-MSH acts on the MC4R to regulate thermogenesis via the 
sympathetic nervous system (Fan et al., 2005; Vaughan, Shrestha, & Bartness, 2011; Voss-
Andreae et al., 2007). Although molecular and physiological mechanisms of PACAP’s 
involvement in BAT activation remain unclear, some evidence exists to suggest PACAP 
interacts with the melanocortin system to activate BAT thermogenesis (Tanida, Shintani, & 
Hashimoto, 2011). This potential association and gap in the literature is the focus of the 
research for Chapter 2. 
Research has shown that both PACAP -/- and melanocortin 4-receptor (MC4R) -/- 
mice have impaired thermogenesis and it is hypothesized that PACAP and the melanocortin 
system are connected in activating BAT thermogenesis (Berglund et al., 2014; Diané et al., 
2014; Fan, Voss-Andreae, Cao, & Morison, 2005; Gray et al., 2002; Voss-Andreae et al., 
2007). It is clear that BAT activation unequivocaly occurs by sympathetic nerve activity 
(SNA) initiated at the level of the hypothalamus, whereby the central sympathetic outflow 
circuits to BAT have been revealed by injecting a retrograde viral transneuronal tract tracer 
into the tissue (Bamshad, Song, & Bartness, 1999; Bartness, Vaughan, & Song, 2010). 
However, the mechanisms by which the hypothalamic nuclei activating BAT are not 
precisely known. Interestingly, a high degree of colocolization of MC4R mRNA is found on 
the neurons along the neuronal tract where the viral tracer is detected (Bartness, Vaughan, & 
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Song, 2010).  Additionaly, when MC4R agonist Melanotan I (MTI) was stereotaxicaly 
injected into the VMN, similar results were observed to those with pharmacological 
injections of PACAP into the VMN; an increase in energy expenditure and thermogenesis, 
suggesting that PACAP and the melanocortin system may share a common pathway in 
activating BAT thermogenesis (Gavini, Jones, & Novak, 2016). Tanida, Shintani, & 
Hashimoto (2011) conducted further research into the connection between PACAP and the 
melanocortin system where they monitored neural response in BAT as opposed to 
thermogenic markers. They performed intracerebroventricular injections of an MC4R 
antagonist, folowed by PACAP, and compared the neural response in BAT to those without 
the antagonist injection. Without the antagonist, PACAP injections showed increased neural 
activity to BAT. However, when the MC4R antagonist was injected before PACAP, very 
litle sympathetic nerve activity was observed at the level of BAT (Tanida, Shintani, & 
Hashimoto 2011). This provides evidence to suggest that PACAP acts upstream of the 
melanocortin system in activating BAT (as proposed in Figure 1.9). Further research is 
necessary to support these results, which wil be presented in Chapter 2. 
1.10 HYPOTHESIS AND RESEARCH OBJECTIVES  
I hypothesize that PACAP acts upstream from the melanocortin system to regulate 
SNA to stimulate adaptive thermogenesis in BAT. Moreover, I hypothesize that the cold 
sensitivity of PACAP -/- mice may be due to the absence of PACAP signaling within the 
VMN specificaly (Figure 1.9). 
The objectives of this research are: 
1. To determine if the impaired thermogenesis in PACAP -/- mice can be 
rescued pharmacologicaly with a melanocortin agonist, Melanotan I (MTI), 
and thus provide evidence using a genetic model of PACAP deficiency for the 
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connection between PACAP and the melanocortin system in regulating 
thermogenesis in BAT 
2. To create an adenoviral construct that expresses GFP under the regulation of 
the SF1 promoter to act as a control vector to be used in stereotaxic surgery, 
thus ensuring VMN-specific expression of the vector  
3. To devise a protocol for stereotaxic injections which reaches the VMN in live 
animals 
Results obtained from objectives 2 and 3 act as preliminary steps folowing future objective: 
4. To create an adenoviral construct for VMN specific expression of PACAP to 
determine if the impaired thermogenesis in PACAP -/- mice can be geneticaly 
rescued by transgenic expression of PACAP in the VMN only, thus 
determining the importance of VMN PACAP in regulating thermogenesis 
The work is presented in self-contained chapters. The focus of Chapter 2 is to 
determine the pathway connecting PACAP and the melanocortin system in activating 
thermogenesis in BAT. This was achieved by injecting PACAP -/- mice with a 
pharmacological MC4R agonist in atempt to rescue impaired thermogenesis in PACAP -/- 
mice. Methodology of assessing the physiological and biochemical markers for thermogenic 
response is discussed in detail in Chapter 2. Chapter 3 focuses on the creation of an 
adenoviral control construct to be used as the initial step in the genetic reintroduction of 
PACAP specificaly in the VMN to determine its role in BAT thermogenesis activation. This 
chapter also includes development of a stereotaxic protocol for injection of the adenovirus 
into the VMN of mice to achieve VMN specific expression of PACAP. Chapter 4 connects 
Chapters 2 and 3, providing a conclusion and significance for research in this area. 
 
 27 
1.11 REFERENCES 
About Obesity in Canada - Canadian Obesity Network. (2016). Obesitynetwork.ca. Retrieved 
2 June 2016, from htp:/www.obesitynetwork.ca/obesity-in-canada 
 
Adams, B., Gray, S., Isaac, E., Bianco, A., Vidal-Puig, A., & Sherwood, N. (2008). Feeding 
and Metabolism in Mice Lacking Pituitary Adenylate Cyclase-Activating 
Polypeptide. Endocrinology, 149(4), 1571-1580. htp:/dx.doi.org/10.1210/en.2007-0515 
 
Adult Obesity Facts | Overweight & Obesity | CDC. (2016). Cdc.gov. Retrieved 2 June 2016, 
from htp:/www.cdc.gov/obesity/data/adult.html 
Ahima, R. (2006). Adipose Tissue as an Endocrine Organ. Obesity, 14, 242S-249S. 
htp:/dx.doi.org/10.1038/oby.2006.317 
 
Balthasar, N., Coppari, R., McMinn, J., Liu, S., Lee, C., & Tang, V. et al. (2004). Leptin 
Receptor Signaling in POMC Neurons Is Required for Normal Body Weight 
Homeostasis. Neuron, 42(6), 983-991. htp:/dx.doi.org/10.1016/j.neuron.2004.06.004 
Bamshad, M., Song, C., & Bartness, T. (1999). CNS origins of the sympathetic nervous 
system outflow to brown adipose tissue. Am J Physiol, 276(6 Pt 2), R1569-78. 
 
Bartelt, A. & Heeren, J. (2013). Adipose tissue browning and metabolic health. Nat Rev 
Endocrinol,10(1), 24-36. htp:/dx.doi.org/10.1038/nrendo.2013.204 
 
Bartness, T., Vaughan, C., & Song, C. (2010). Sympathetic and sensory innervation of brown 
adipose tissue. Int J Obes Relat Metab Disord, 34, S36-S42. 
htp:/dx.doi.org/10.1038/ijo.2010.182 
 
Berglund, E., Liu, T., Kong, X., Sohn, J., Vong, L., & Deng, Z. et al. (2014). Melanocortin 4 
receptors in autonomic neurons regulate thermogenesis and glycemia. Nature 
Neuroscience, 17(7), 911-913. http:/dx.doi.org/10.1038/nn.3737 
Bingham, N., Anderson, K., Reuter, A., Stalings, N., & Parker, K. (2008). Selective Loss of 
Leptin Receptors in the Ventromedial Hypothalamic Nucleus Results in Increased 
Adiposity and a Metabolic Syndrome. Endocrinology, 149(5), 2138-2148. 
htp:/dx.doi.org/10.1210/en.2007-1200 
 
Blondin, D., Labbé, S., Phoenix, S., Guérin, B., Turcote, É., & Richard, D. et al. (2014). 
Contributions of white and brown adipose tissues and skeletal muscles to acute cold-
induced metabolic responses in healthy men. J Physiol, 593(3), 701-714. 
htp:/dx.doi.org/10.1113/jphysiol.2014.283598 
 
Bowen, R. (2006). Adrenocorticotropic Hormone (ACTH, corticotropin). In R. 
Bowen, Pathophysiology of the Endocrine System (1st ed.). Colorado. Retrieved from 
htp:/www.vivo.colostate.edu/hbooks/pathphys/endocrine/hypopit/acth.html 
 
 28 
Butler, A., & Cone, R. (2002). The melanocortin receptors: Lessons from knockout 
models. Neuropeptides, 36(2-3), 77-84. htp:/dx.doi.org/10.1054/npep.2002.0890 
Chalis, B., Col, A., Yeo, G., Pinnock, S., Dickson, S., & Thresher, R. et al. (2004). Mice 
lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normaly to 
the acute anorectic efects of peptide-YY3-36. Proceedings Of The National Academy 
Of Sciences, 101(13), 4695-4700. htp:/dx.doi.org/10.1073/pnas.0306931101 
Chechi, K., Carpentier, A., & Richard, D. (2013). Understanding the brown adipocyte as a 
contributor to energy homeostasis. Trends In Endocrinology & Metabolism, 24(8), 408-
420. htp:/dx.doi.org/10.1016/j.tem.2013.04.002 
Chen, K., Brychta, R., Linderman, J., Smith, S., Courvile, A., & Dieckmann, W. et al. 
(2013). Brown Fat Activation Mediates Cold-Induced Thermogenesis in Adult Humans 
in Response to a Mild Decrease in Ambient Temperature. The Journal Of Clinical 
Endocrinology & Metabolism, 98(7), E1218-E1223. htp:/dx.doi.org/10.1210/jc.2012-
4213 
Choi, Y., Fujikawa, T., Lee, J., Reuter, A., & Kim, K. (2013). Revisiting the Ventral Medial 
Nucleus of the Hypothalamus: The Roles of SF-1 Neurons in Energy 
Homeostasis. Frontiers In Neuroscience, 7. htp:/dx.doi.org/10.3389/fnins.2013.00071 
 
Chondronikola, M., Volpi, E., Børsheim, E., Porter, C., Saraf, M., & Annamalai, P. et al. 
(2016). Brown Adipose Tissue Activation Is Linked to Distinct Systemic Efects on 
Lipid Metabolism in Humans. Cel Metabolism, 23(6), 1200-1206. 
htp:/dx.doi.org/10.1016/j.cmet.2016.04.029 
Choquet, H. & Meyre, D. (2011). Genetics of Obesity: What have we Learned?. CG, 12(3), 
169-179. htp:/dx.doi.org/10.2174/138920211795677895 
 
Cone, R. (1999). The Central Melanocortin System and Energy Homeostasis. Trends In 
Endocrinology & Metabolism, 10(6), 211-216. htp:/dx.doi.org/10.1016/s1043-
2760(99)00153-8 
 
Cone, R. (2005). Anatomy and regulation of the central melanocortin system. Nature 
Neuroscience, 8(5), 571-578. htp:/dx.doi.org/10.1038/nn1455 
Diané, A., Nikolic, N., Rudecki, A., King, S., Bowie, D., & Gray, S. (2014). PACAP is 
essential for the adaptive thermogenic response of brown adipose tissue to cold 
exposure. Journal Of Endocrinology, 222(3), 327-339. htp:/dx.doi.org/10.1530/joe-14-
0316 
Dubern, B., Lubrano-Berthelier, C., Mencareli, M., Ersoy, B., Frelut, M., & Bouglé, D. et al. 
(2008). Mutational Analysis of the Pro-opiomelanocortin Gene in French Obese 
Children Led to the Identification of a Novel Deleterious Heterozygous Mutation 
Located in the α-Melanocyte Stimulating Hormone Domain. Pediatr Res, 63(2), 211-
216. htp:/dx.doi.org/10.1203/pdr.0b013e31815ed62b 
 
 29 
Elacot, K. & Cone, R. (2006). The role of the central melanocortin system in the regulation 
of food intake and energy homeostasis: lessons from mouse models. Philosophical 
Transactions Of The Royal Society B: Biological Sciences, 361(1471), 1265-1274. 
htp:/dx.doi.org/10.1098/rstb.2006.1861 
 
Enerbäck, S., Jacobsson, A., Simpson, E., Guera, C., Yamashita, H., Harper, M., & Kozak, 
L. (1997). Mice lacking mitochondrial uncoupling protein are cold-sensitive but not 
obese. Nature,387(6628), 90-94. htp:/dx.doi.org/10.1038/387090a0 
 
Fan, W., Voss-Andreae, A., Cao, W., & Morison, S. (2005). Regulation of thermogenesis by 
the central melanocortin system. Peptides, 26(10), 1800-1813. 
htp:/dx.doi.org/10.1016/j.peptides.2004.11.033 
Farooqi, I. & O’Rahily, S. (2006). Genetics of Obesity in Humans. Endocrine 
Reviews, 27(7), 710-718. htp:/dx.doi.org/10.1210/er.2006-0040 
Feldmann, H., Golozoubova, V., Cannon, B., & Nedergaard, J. (2009). UCP1 Ablation 
Induces Obesity and Abolishes Diet-Induced Thermogenesis in Mice Exempt from 
Thermal Stress by Living at Thermoneutrality. Cel Metabolism, 9(2), 203-209. 
htp:/dx.doi.org/10.1016/j.cmet.2008.12.014 
Finucane, M., Stevens, G., Cowan, M., Danaei, G., Lin, J., & Paciorek, C. et al. (2011). 
National, regional, and global trends in body-mass index since 1980: systematic analysis 
of health examination surveys and epidemiological studies with 960 country-years and 
9·1 milion participants. The Lancet, 377(9765), 557-567. 
htp:/dx.doi.org/10.1016/s0140-6736(10)62037-5 
 
Flier, J. (2004). Obesity Wars: Molecular Progress Confronts an Expanding 
Epidemic. Cel, 116(2), 337-350. htp:/dx.doi.org/10.1016/s0092-8674(03)01081-x 
Fonseca-Alaniz, M., Takada, J., Alonso-Vale, M., & Lima, F. (2007). Adipose tissue as an 
endocrine organ: from theory to practice. J Pediatr (Rio J), 0(0). 
htp:/dx.doi.org/10.2223/jped.1709 
 
Galic, S., Oakhil, J., & Steinberg, G. (2010). Adipose tissue as an endocrine 
organ. Molecular And Celular Endocrinology, 316(2), 129-139. 
htp:/dx.doi.org/10.1016/j.mce.2009.08.018 
 
Gavini, C., Jones, W., & Novak, C. (2016). Ventromedial hypothalamic melanocortin 
receptor activation: regulation of activity energy expenditure and skeletal muscle 
thermogenesis. The Journal Of Physiology, 594(18), 5285-5301. 
htp:/dx.doi.org/10.1113/jp272352 
Gavrilova, O., Marcus-Samuels, B., Graham, D., Kim, J., Shulman, G., & Castle, A. et al. 
(2000). Surgical implantation of adipose tissue reverses diabetes in lipoatrophic 
mice. Journal Of Clinical Investigation, 105(3), 271-278. 
htp:/dx.doi.org/10.1172/jci7901 
 30 
Giralt, M., & Vilaroya, F. (2013). White, Brown, Beige/Brite: Diferent Adipose Cels for 
Diferent Functions?. Endocrinology, 154(9), 2992-3000. 
htp:/dx.doi.org/10.1210/en.2013-1403 
Gray, S., Cummings, K., Jirik, F., & Sherwood, N. (2001). Targeted Disruption of the 
Pituitary Adenylate Cyclase-Activating Polypeptide Gene Results in Early Postnatal 
Death Associated with Dysfunction of Lipid and Carbohydrate Metabolism. Molecular 
Endocrinology, 15(10), 1739-1747. htp:/dx.doi.org/10.1210/mend.15.10.0705 
 
Gray, S., Yamaguchi, N., Vencova, P., & Sherwood, N. (2002). Temperature-Sensitive 
Phenotype in Mice Lacking Pituitary Adenylate Cyclase-Activating 
Polypeptide. Endocrinology, 143(10), 3946-3954. htp:/dx.doi.org/10.1210/en.2002-
220401 
 
Greenberg, A. & Obin, M. (2006). Obesity and the role of adipose tissue in inflammation and 
metabolism. The American Journal Of Clinical Nutrition, 83, 461-465. 
 
Greenman, Y., Kuperman, Y., Drori, Y., Asa, S., Navon, I., & Forkosh, O. et al. (2013). 
Postnatal Ablation of POMC Neurons Induces an Obese Phenotype Characterized by 
Decreased Food Intake and Enhanced Anxiety-Like Behavior. Molecular 
Endocrinology, 27(7), 1091-1102. htp:/dx.doi.org/10.1210/me.2012-1344 
Halaas, J., Gajiwala, K., Mafei, M., Cohen, S., Chait, B., & Rabinowitz, D. et al. (1995). 
Weight-reducing efects of the plasma protein encoded by the obese 
gene. Science, 269(5223), 543-546. htp:/dx.doi.org/10.1126/science.7624777 
Hany, T., Gharehpapagh, E., Kamel, E., Buck, A., Himms-Hagen, J., & von Schulthess, G. 
(2002). Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the 
neck and upper chest region. European Journal Of Nuclear Medicine And Molecular 
Imaging, 29(10), 1393-1398. htp:/dx.doi.org/10.1007/s00259-002-0902-6 
 
Harwood, H. (2012). The adipocyte as an endocrine organ in the regulation of metabolic 
homeostasis.Neuropharmacology, 63(1), 57-75. 
htp:/dx.doi.org/10.1016/j.neuropharm.2011.12.010 
Hashimoto, H., Nogi, H., Mori, K., Ohishi, H., Shigemoto, R., & Yamamoto, K. et al. (1996). 
Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide 
receptor in the rat brain: An in situ hybridization study. The Journal Of Comparative 
Neurology, 371(4), 567-577. htp:/dx.doi.org/10.1002/(sici)1096-
9861(19960805)371:4<567:aid-cne6>3.3.co;2-m 
 
Havel, P. (2002). Control of energy homeostasis and insulin action by adipocyte hormones: 
leptin, acylation stimulating protein, and adiponectin. Current Opinion In 
Lipidology, 13(1), 51-59. htp:/dx.doi.org/10.1097/00041433-200202000-00008 
 
Hawke, Z., Ivanov, T., Bechtold, D., Dhilon, H., Lowel, B., & Luckman, S. (2009). PACAP 
Neurons in the Hypothalamic Ventromedial Nucleus Are Targets of Central Leptin 
 31 
Signaling. Journal Of Neuroscience, 29(47), 14828-14835. 
htp:/dx.doi.org/10.1523/jneurosci.1526-09.2009 
Hinney, A., Vogel, C., & Hebebrand, J. (2010). From monogenic to polygenic obesity: recent 
advances.European Child & Adolescent Psychiatry, 19(3), 297-310. 
htp:/dx.doi.org/10.1007/s00787-010-0096-6 
How, S. (2016). Satiety Gene Variants as Markers for Obesity. Utar.edu.my. Retrieved 5 
August 2016, from 
htp:/www.utar.edu.my/contentRandD.jsp?catid=9&contentid=417&2ndcontentid=1957 
 
Hwa, J., Ghibaudi, L., Compton, D., Fawzi, A., & Strader, C. (1996). Intracerebroventricular 
Injection of Leptin Increases Thermogenesis and Mobilizes Fat Metabolism in 
ob/obMice. Hormone And Metabolic Research, 28(12), 659-663. 
htp:/dx.doi.org/10.1055/s-2007-979873 
Jeong, J., Kim, J., & Lee, B. (2014). Participation of the central melanocortin system in 
metabolic regulation and energy homeostasis. Cel. Mol. Life Sci., 71(19), 3799-3809. 
htp:/dx.doi.org/10.1007/s00018-014-1650-z 
 
Kooijman, S., Boon, M., Parlevliet, E., Geerling, J., van de Pol, V., & Romijn, J. et al. 
(2014). Inhibition of the central melanocortin system decreases brown adipose tissue 
activity. The Journal Of Lipid Research, 55(10), 2022-2032. 
htp:/dx.doi.org/10.1194/jlr.m045989 
 
Kopecky, J., Clarke, G., Enerbäck, S., Spiegelman, B., & Kozak, L. (1995). Expression of the 
mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic 
obesity.Journal Of Clinical Investigation, 96(6), 2914-2923. 
htp:/dx.doi.org/10.1172/jci118363 
 
Krude, H., Bierbermann, H., Luck, W., Horn, R., Brabant, G., & Gruters, A. (1999). Severe 
Early-Onset Obesity, Adrenal Insuficiency and Red Hair Pigmentation Caused by 
POMC Mutations in Humans. Nat Genet, 19(2), 155-7. 
 
Labbé, S., Caron, A., Lanfray, D., Monge-Rofarelo, B., Bartness, T., & Richard, D. (2015). 
Hypothalamic control of brown adipose tissue thermogenesis. Front. Syst. Neurosci., 9. 
htp:/dx.doi.org/10.3389/fnsys.2015.00150 
 
Lee, B. & Shao, J. (2014). Adiponectin and energy homeostasis. Rev Endocr Metab 
Disord, 15(2), 149-156. htp:/dx.doi.org/10.1007/s11154-013-9283-3 
Li, G., Mobbs, C., & Scarpace, P. (2003). Central Pro-opiomelanocortin Gene Delivery 
Results in Hypophagia, Reduced Visceral Adiposity, and Improved Insulin Sensitivity in 
Geneticaly Obese Zucker Rats. Diabetes, 52(8), 1951-1957. 
htp:/dx.doi.org/10.2337/diabetes.52.8.1951 
Lidel, M., Betz, M., & Enerbäck, S. (2014). Brown adipose tissue and its therapeutic 
potential. J Intern Med, 276(4), 364-377. htp:/dx.doi.org/10.1111/joim.12255 
 32 
Lim, S., Honek, J., Xue, Y., Seki, T., Cao, Z., & Andersson, P. et al. (2012). Cold-induced 
activation of brown adipose tissue and adipose angiogenesis in mice. Nat Protoc, 7(3), 
606-615. htp:/dx.doi.org/10.1038/nprot.2012.013 
 
Lowel, B., S-Susulic, V., Hamann, A., Lawits, J., Himms-Hagen, J., & Boyer, B. et al. 
(1993). Development of obesity in transgenic mice after genetic ablation of brown 
adipose tissue. Nature,366(6457), 740-742. htp:/dx.doi.org/10.1038/366740a0 
 
Miyata, A., Arimura, A., Dahl, R., Minamino, N., Uehara, A., & Jiang, L. et al. (1989). 
Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate 
cyclase in pituitary cels. Biochemical And Biophysical Research 
Communications, 164(1), 567-574. htp:/dx.doi.org/10.1016/0006-291x(89)91757-9 
Moitra, J., Mason, M., Olive, M., Krylov, D., Gavrilova, O., & Marcus-Samuels, B. et al. 
(1998). Life without white fat: a transgenic mouse. Genes & Development, 12(20), 3168-
3181. htp:/dx.doi.org/10.1101/gad.12.20.3168 
Morison, S. (2016). Central control of body temperature. F1000research, 5, 880. 
htp:/dx.doi.org/10.12688/f1000research.7958.1 
Mizuno, T., Keley, K., Pasineti, G., Roberts, J., & Mobbs, C. (2003). Transgenic Neuronal 
Expression of Proopiomelanocortin Atenuates Hyperphagic Response to Fasting and 
Reverses Metabolic Impairments in Leptin-Deficient Obese Mice. Diabetes, 52(11), 
2675-2683. htp:/dx.doi.org/10.2337/diabetes.52.11.2675 
 
Mueler, W., Gregoire, F., Stanhope, K., Mobbs, C., Mizuno, T., & Warden, C. et al. (1998). 
Evidence That Glucose Metabolism Regulates Leptin Secretion from Cultured Rat 
Adipocytes 1. Endocrinology, 139(2), 551-558. 
htp:/dx.doi.org/10.1210/endo.139.2.5716 
Nakata, M., Kohno, D., Shintani, N., Nemoto, Y., Hashimoto, H., Baba, A., & Yada, T. 
(2004). PACAP deficient mice display reduced carbohydrate intake and PACAP 
activates NPY-containing neurons in the rat hypothalamic arcuate nucleus. Neuroscience 
Leters, 370(2-3), 252-256. htp:/dx.doi.org/10.1016/j.neulet.2004.08.034 
 
Nakata, M., Shioda, S., Oka, Y., Maruyama, I., & Yada, T. (1999). Insulinotropin PACAP 
potentiates insulin-stimulated glucose uptake in 3T3 L1 cels☆. Peptides, 20(8), 943-
948. htp:/dx.doi.org/10.1016/s0196-9781(99)00085-6 
Nakata, M. & Yada, T. (2007). PACAP in the Glucose and Energy Homeostasis: 
Physiological Role and Therapeutic Potential. CPD, 13(11), 1105-1112. 
htp:/dx.doi.org/10.2174/138161207780618948 
Nedergaard, J., Bengtsson, T., & Cannon, B. (2007). Unexpected evidence for active brown 
adipose tissue in adult humans. AJP: Endocrinology And Metabolism, 293(2), E444-
E452. htp:/dx.doi.org/10.1152/ajpendo.00691.2006 
 
Obesity and overweight. (2016). World Health Organization. Retrieved 2 June 2016, from 
htp:/www.who.int/mediacentre/factsheets/fs311/en/ 
 33 
Peirce, V., Carobbio, S., & Vidal-Puig, A. (2014). The diferent shades of 
fat. Nature, 510(7503), 76-83. htp:/dx.doi.org/10.1038/nature13477 
 
Pfannenberg, C., Werner, M., Ripkens, S., Stef, I., Deckert, A., & Schmadl, M. et al. (2010). 
Impact of Age on the Relationships of Brown Adipose Tissue With Sex and Adiposity in 
Humans. Diabetes, 59(7), 1789-1793. htp:/dx.doi.org/10.2337/db10-0004 
 
Resch, J., Boisvert, J., Hourigan, A., Mueler, C., Yi, S., & Choi, S. (2011). Stimulation of 
the hypothalamic ventromedial nuclei by pituitary adenylate cyclase-activating 
polypeptide induces hypophagia and thermogenesis. AJP: Regulatory, Integrative And 
Comparative Physiology, 301(6), R1625-R1634. 
htp:/dx.doi.org/10.1152/ajpregu.00334.2011 
 
Resch, J., Maunze, B., Gerhardt, A., Magnuson, S., Philips, K., & Choi, S. (2013). 
Intrahypothalamic pituitary adenylate cyclase-activating polypeptide regulates energy 
balance via site-specific actions on feeding and metabolism. AJP: Endocrinology And 
Metabolism, 305(12), E1452-E1463. htp:/dx.doi.org/10.1152/ajpendo.00293.2013 
 
Rudecki, A. & Gray, S. (2016). PACAP in the Defense of Energy Homeostasis. Trends In 
Endocrinology & Metabolism. htp:/dx.doi.org/10.1016/j.tem.2016.04.008 
 
Saito, M. (2013). Brown adipose tissue as a therapeutic target for human obesity. Obesity 
Research & Clinical Practice, 7(6), e432-e438. 
htp:/dx.doi.org/10.1016/j.orcp.2013.09.001 
Saito, M., Yoneshiro, T., & Matsushita, M. (2016). Activation and recruitment of brown 
adipose tissue by cold exposure and food ingredients in humans. Best Practice & 
Research Clinical Endocrinology & Metabolism, 30(4), 537-547. 
htp:/dx.doi.org/10.1016/j.beem.2016.08.003 
Sakurai, T., Ogasawara, J., Kizaki, T., Sato, S., Ishibashi, Y., & Takahashi, M. et al. (2013). 
The Efects of Exercise Training on Obesity-Induced Dysregulated Expression of 
Adipokines in White Adipose Tissue. International Journal Of Endocrinology, 2013, 1-
28. htp:/dx.doi.org/10.1155/2013/801743 
 
Satoh, N., Ogawa, Y., Katsuura, G., Numata, Y., Tsuji, T., & Hayase, M. et al. (1999). 
Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced 
increase in catecholamine secretion. Diabetes, 48(9), 1787-1793. 
htp:/dx.doi.org/10.2337/diabetes.48.9.1787 
 
Scarpace, P., Matheny, M., Polock, B., & Tumer, N. (1997). Leptin increases uncoupling 
protein expression and energy expenditure. American Journal Of Physiology - 
Endocrinology And Metabolism, 273(1), E226-E230. 
 
Stern, J., Rutkowski, J., & Scherer, P. (2016). Adiponectin, Leptin, and Faty Acids in the 
Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. Cel 
Metabolism, 23(5), 770-784. htp:/dx.doi.org/10.1016/j.cmet.2016.04.011 
 34 
 
Tabeta, K., & Beutler, B. (2012). Mutagenetix - LabArchives, Your Electronic Lab 
Notebook. Mynotebook.labarchives.com. Retrieved 26 April 2017, from 
htps:/mynotebook.labarchives.com/share/Mutagenetix/MjMyLjd8MzA4My8xNzkvVH
JlZU5vZGUvMTV8NTkwLjc= 
 
Tanida, M., Shintani, N., & Hashimoto, H. (2011). The melanocortin system is involved in 
regulating autonomic nerve activity through central pituitary adenylate cyclase-
activating polypeptide. Neuroscience Research, 70(1), 55-61. 
htp:/dx.doi.org/10.1016/j.neures.2011.01.014 
 
Thermogenesis. (2016). En.wikipedia.org. Retrieved 20 November 2016, from 
htps:/en.wikipedia.org/wiki/Thermogenesis 
 
Trayhurn, P. (2005). Endocrine and signaling role of adipose tissue: new perspectives on 
fat. Acta Physiologica Scandinavica, 184(4), 285-293. htp:/dx.doi.org/10.1111/j.1365-
201x.2005.01468.x 
 
Trayhurn, P. & Beatie, J. (2001). Physiological role of adipose tissue: white adipose tissue as 
an endocrine and secretory organ. Proceedings Of The Nutrition Society, 60(03), 329-
339. htp:/dx.doi.org/10.1079/pns200194 
 
van Marken Lichtenbelt, W., Vanhommerig, J., Smulders, N., Drossaerts, J., Kemerink, G., 
& Bouvy, N. et al. (2009). Cold-Activated Brown Adipose Tissue in Healthy Men. New 
England Journal Of Medicine, 360(15), 1500-1508. 
htp:/dx.doi.org/10.1056/nejmoa0808718 
 
Vaudry, D., Faluel-Morel, A., Bourgault, S., Basile, M., Burel, D., & Wurtz, O. et al. 
(2009). Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years 
after the Discovery.Pharmacological Reviews, 61(3), 283-357. 
htp:/dx.doi.org/10.1124/pr.109.001370 
 
Vaughan, C., Shrestha, Y., & Bartness, T. (2011). Characterization of a novel melanocortin 
receptor-containing node in the SNS outflow circuitry to brown adipose tissue involved 
in thermogenesis. Brain Research, 1411, 17-27. 
htp:/dx.doi.org/10.1016/j.brainres.2011.07.003 
 
Vázquez-Vela, M., Tores, N., & Tovar, A. (2008). White Adipose Tissue as Endocrine 
Organ and Its Role in Obesity. Archives Of Medical Research, 39(8), 715-728. 
htp:/dx.doi.org/10.1016/j.arcmed.2008.09.005 
 
Vijgen, G., Bouvy, N., Teule, G., Brans, B., Schrauwen, P., & van Marken Lichtenbelt, W. 
(2011). Brown Adipose Tissue in Morbidly Obese Subjects. Plos ONE, 6(2), e17247. 
htp:/dx.doi.org/10.1371/journal.pone.0017247 
 
Voss-Andreae, A., Murphy, J., Elacot, K., Stuart, R., Nilni, E., Cone, R., & Fan, W. 
(2007). Role of the Central Melanocortin Circuitry in Adaptive Thermogenesis of 
 35 
Brown Adipose Tissue.Endocrinology, 148(4), 1550-1560. 
htp:/dx.doi.org/10.1210/en.2006-1389 
 
Waley, A. (2006). Genetics of obesity and the prediction of risk for health. Human 
Molecular Genetics,15(Review Issue 2), R124-R130. 
htp:/dx.doi.org/10.1093/hmg/ddl215 
 
Wang, Q., Zhang, M., Xu, M., Gu, W., Xi, Y., & Qi, L. et al. (2015). Brown Adipose Tissue 
Activation Is Inversely Related to Central Obesity and Metabolic Parameters in Adult 
Human. PLOS ONE, 10(4), e0123795. htp:/dx.doi.org/10.1371/journal.pone.0123795 
Westerterp-Plantenga, M., Saris, W., Huckshorn, C., & Campfield, L. (2001). Efects of 
weekly administration of pegylated recombinant human OB protein on appetite profile 
and energy metabolism in obese men. Am J Clin Nutr, 74(4), 426-34. 
 
WHO | Controling the global obesity epidemic. (2016). Who.int. Retrieved 2 June 2016, 
from htp:/www.who.int/nutrition/topics/obesity/en/ 
 
WHO | Obesity. (2016). Who.int. Retrieved 2 June 2016, from 
htp:/www.who.int/gho/ncd/risk_factors/obesity_text/en/ 
 
Xu, Z., Ohtaki, H., Watanabe, J., Miyamoto, K., Murai, N., & Sasaki, S. et al. (2016). 
Pituitary adenylate cyclase-activating polypeptide (PACAP) contributes to the 
proliferation of hematopoietic progenitor cels in murine bone marow via PACAP-
specific receptor. Sci. Rep., 6, 22373. htp:/dx.doi.org/10.1038/srep22373 
 
Yaswen, L., Diehl, N., Brennan, M., & Hochgeschwender, U. (1999). Obesity in the mouse 
model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat 
Med, 5(9), 1066-70. 
 
Yeo, G. & Heisler, L. (2012). Unraveling the brain regulation of appetite: lessons from 
genetics. Nature Neuroscience, 15(10), 1343-1349. htp:/dx.doi.org/10.1038/nn.3211 
Yoneshiro, T., Aita, S., Matsushita, M., Okamatsu-Ogura, Y., Kameya, T., & Kawai, Y. et al. 
(2011). Age-Related Decrease in Cold-Activated Brown Adipose Tissue and 
Accumulation of Body Fat in Healthy Humans. Obesity, 19(9), 1755-1760. 
htp:/dx.doi.org/10.1038/oby.2011.125 
Yoo, H., Qiao, L., Bosco, C., Leong, L., Lytle, N., & Feng, G. et al. (2014). Intermitent Cold 
Exposure Enhances Fat Accumulation in Mice. Plos ONE, 9(5), e96432. 
htp:/dx.doi.org/10.1371/journal.pone.0096432 
 
Zhang, Y., Proenca, R., Mafei, M., Barone, M., Leopold, L., & Friedman, J. (1994). 
Positional cloning of the mouse obese gene and its human 
homologue. Nature, 372(6505), 425-432. htp:/dx.doi.org/10.1038/372425a 
 
 
 
 36 
 
 
 
 
 
 
 
 
CHAPTER 2 
Pharmacological Intervention with Melanotan II Partialy Rescues the Impaired 
Thermogenic Capacity of PACAP -/- Mice 
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2.1 INTRODUCTION 
 Owing to the thermogenic capabilities of brown and beige adipocytes, the recent 
discovery that BAT is present and functional in adult humans has atracted increasing 
atention to this tissue, particularly due to its energy dissipating activity and potential 
protective function against body fat accumulation (Chen et al., 2013; Chondronikolina et al., 
2016; Saito, Yoneshiro, & Matsushita, 2016). While several endocrine regulators are 
involved in the activation of BAT such as thyroid hormones, heart natriuretic peptides and 
liver bile acids, the greatest physiological stimulus is via sympathetic activation, which is 
induced in response to both feeding and cold exposure (Figure 2.1) (Chechi, Carpentier, & 
Richard, 2013; Labbé et al., 2015; Saito, Yoneshiro, & Matsushita, 2016). The focus of this 
chapter wil be to further understand the mechanisms by which sympathetic nerve activity is 
activated in response to cold exposure.  
Cold stress is initialy identified by sensory neurons on the body surface that transmit 
neurochemical signals to the brain, resulting in increased sympathetic activity (Figure 2.1) 
(Morison, & Nakamura, 2011). Norepinephrine (NE) is released from abundantly distributed 
sympathetic nerve endings that innervate BAT and stimulate brown adipocytes via binding 
primarily to β3-adrenergic receptors (β3-ARs) (Inokuma et al., 2005; Saito, Yoneshiro, & 
Matsushita, 2016). This triggers cAMP-activated celular events including hydrolysis of 
triglycerides via hormone sensitive lipase (HSL), oxidation of resulting FAs, and activation 
of uncoupling protein 1 (UCP1); the key mitochondrial protein involved in adaptive 
thermogenesis, resulting in heat production (Figure 1.8) (Inokuma et al., 2005; Saito, 
Yoneshiro, & Matsushita, 2016). Sympathetic activation also results in increased fat 
mobilization in WAT, releasing FAs that are used by peripheral tissues, such as BAT 
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Figure 2.1. Sympathetic and endocrine control of BAT thermogenesis. βAR; beta-adrenergic 
receptor, NE; norepinephrine, NP; natriuretic peptide, T4; thyroxine, UCP1; uncoupling protein 1, 
WAT; white adipose tissue. Adapted from “Activation and recruitment of brown adipose tissue by 
cold exposure and food ingredients in humans”, by M. Saito, T. Yoneshiro, & M. Matsushita, 
2016, Best Practice & Research Clinical Endocrinology & Metabolism, 30(4), 537-547. Copyright © 
2017 Elsevier B.V. Adapted with permission from publisher. 
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where they are used as a substrate for oxidative metabolism (Chondronikola et al., 2016; 
Saito, Yoneshiro, & Matsushita, 2016). Changes in adaptive thermogenesis can be measured 
along the pathways indicated in Figure 2.1 through the folowing: measurements of SNA and 
NE turnover at the level of BAT, thermogenic gene and protein expression of β3-ARs, HSL 
and UCP1 in BAT, measurements of oxygen consumption (energy expenditure) using 
indirect calorimetry, core body temperature and BAT temperature, as wel as examination of 
histological changes of BAT morphology indicative of thermogenic activity (Cannon, & 
Nedergaard, 2010; Crane et al., 2014; Rothwel, 2001; Virtue, & Vidal-Puig, 2013). For 
example, mice housed at thermoneutrality (30°C) exhibit inactive adaptive thermogenesis, 
resulting in the accumulation of lipids in both WAT and BAT (Goldgof et al., 2014; 
Heldmaier, 1975; Virtue, & Vidal-Puig, 2013). Histologicaly, WAT in animals housed at 
thermoneutrality presents with large, lipid-filed adipocytes, while BAT in animals housed at 
thermoneutrality presents with large, multilocular lipid droplets within brown adipocytes 
(Goldgof et al., 2014; Heldmaier, 1975; Virtue, & Vidal-Puig, 2013). In contrast, adaptive 
thermogenesis is maximaly active in BAT during cold exposure (4°C), resulting in the 
breakdown of triglycerides in both WAT and BAT, to release FAs that fuel thermogenesis 
(Chondronikola et al., 2016; Ngyuen et al., 2011; Saito, Yoneshiro, & Matsushita, 2016). 
Therefore, the resulting histological appearance of WAT in cold-exposed animals consists of 
smaler white adipocytes and increased numbers of thermogenicaly active, beige adipocytes, 
while BAT in cold-exposed animals contains brown adipocytes with smaler, multilocular 
lipid droplets (Heldmaier, 1975; Nguyen et al., 2011; Virtue, & Vidal-Puig, 2013).  
Activation of BAT by cold exposure has been repeatedly demonstrated in humans, as 
visualized with (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET). In 
response to short-term mild cold exposure (15-19°C), both blood flow and glucose uptake in 
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human BAT increases, as wel as whole body energy expenditure (Chen et al., 2013; Orava et 
al., 2011; Muzik et al., 2013; Ouelet et al., 2012; Yoneshiro et al., 2010). Notably, these 
results are observed only in individuals that possess significant amounts of BAT. Studies 
have shown that BAT activity is inversely related to BMI and body fat percentage such that 
activity is lower in obese subjects as compared to lean individuals (van Marken Lichtenbelt 
et al., 2009; van Marken Lichtenbelt, 2011; Vijgen et al., 2011; Wang et al., 2015). To 
determine if low levels of BAT activity could be increased, Yoneshiro et al. (2013) exposed 
subjects with low or undetectable levels of BAT to repeated cold exposure over 6 weeks. 
Results indicated both an increase in BAT activity and a decrease in body fat mass 
(Yoneshiro et al., 2013). Importantly, the change in body fat mass was inversely corelated 
with BAT activity, suggesting an important interaction between BAT recruitment and body 
fat reduction (Yoneshiro et al., 2013). Taking the literature into consideration, it is therefore 
conceivable that BAT may be a promising target for combating obesity and related 
metabolic disorders in humans, by restoring BAT activity to the upper range of 
physiologicaly normal levels. In order to determine efective therapeutic targets, however, 
physiological mechanisms and pathways regulating BAT activation through SNA must be 
further elucidated. 
As discussed in Chapter 1, the mechanism of interest and focus of this chapter is the 
potential connection between PACAP and the melanocortin system in the activation of SNA 
in BAT thermogenesis. The evidence demonstrating both PACAP and the melanocortin 
system’s involvement in BAT activation introduced in Chapter 1 wil be further discussed 
here. 
As a result of PACAP’s pleiotropic biological actions as a neuropeptide and its role as 
a master stress regulator, PACAP -/- mice have been shown to have several sympatheticaly 
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controled abnormalities including respiratory control defects, impaired counter-regulatory 
response to hypoglycaemia, and impaired thermogenesis (Adams et al., 2008; Cummings, 
Pendlebury, Sherwood, & Wilson, 2004; Diané et al., 2014; Gray, Cummings, Jirik, & 
Sherwood, 2001; Gray, Yamaguchi, Vencova, & Sherwood, 2002). Consequently, PACAP -
/- mice displayed high rates of mortality, particularly in early post-natal life (Gray et al., 
2001; Gray et al., 2002). Notably, mice that did not survive exhibited severely depleted 
adipose tissue and additional dysfunctions in lipid and carbohydrate metabolism, absent in 
those that did survive, indicating the complexity of the PACAP -/- phenotype (Gray et al., 
2011). Interestingly, the mortality rate of PACAP -/- pups decreased significantly when mice 
were raised at 24°C rather than 21°C, indicating a temperature-sensitive phenotype (Gray et 
al., 2002). This temperature-sensitive phenotype was further supported by the reduced 
thermogenic capacity displayed in adult PACAP -/- mice as compared to PACAP +/+ mice 
during a 4°C cold chalenge, as indicated by reduced levels of NE and expression of β3-ARs, 
impaired upregulation of UCP1 protein, and reduced oxygen consumption during NE-
induced thermogenesis (Diané et al., 2014; Gray et al., 2002). Further evidence for PACAP’s 
role in adaptive thermogenesis originate from pharmacological studies that include the 
injection of PACAP into the third cerebral ventricle of PACAP -/- mice, intrathecal 
administrations of PACAP in healthy rats, and VMN injections of PACAP in wildtype mice; 
al of which resulted in increased BAT thermogenesis, indicated by increased SNA to BAT 
and NE-secreting neuroendocrine cels, increased core body temperature, and upregulated 
UCP1 mRNA expression (Inglot, Farnham, & Pilowsky, 2011; Resch et al., 2011; Resch et 
al., 2013; Tanida et al., 2010). Conclusively, PACAP is deemed essential for the thermogenic 
response in BAT. 
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 Similarly to PACAP, the central melanocortin system also plays a critical role in 
energy homeostasis in both animals and humans. In particular, the melanocortin 4 receptor 
(MC4R) signaling pathway influences both energy intake and energy expenditure (discussed 
in Chapter 1), including thermogenesis with binding of the melanocortin peptide, α-MSH 
(Berglund et al., 2014; Fan, Voss-Andreae, Cao, & Morison, 2005). As a result, MC4R -/- 
mice exhibit increased adiposity and weight gain due to both increased food intake and 
decreased energy expenditure via reduced physical activity and thermogenesis (Berglund et 
al., 2014; Butler & Cone, 2003; Butler et al., 2001; Cone, 1999). Additionaly, MC4R -/- 
mice exhibit a defect in BAT UCP1 upregulation in response to cold exposure, as compared 
to MC4R +/+ mice (Berglund et al., 2014; Voss-Andreae et al., 2007). To mimic the 
biological action of α-MSH, Melanotan I (MTI), a synthetic MC3/4R agonist, was designed 
and synthesized in 1989 by Al-Obeidi et al. Because the activity of MC3Rs in energy 
homeostasis is much more subtle than MC4Rs, the focus here wil be on MC4Rs (Girardet & 
Butler, 2014; Tao, 2010). Upon both peripheral and central (intracerebroventricular (ICV) 
delivery of MTI, thermogenesis was increased in MC4R -/- and +/+ mice, wildtype rats and 
wildtype hamsters, as observed by increased oxygen consumption and SNA to BAT through 
NE turnover, increased BAT temperatures and UCP1 mRNA expression, and decreased 
weight and adiposity through WAT lipolysis in diet-induced obese phenotypes (Brito et al., 
2007; Enriori et al., 2011; Fan, Morison, Cao, & Yu, 2007; Gavini, Jones, & Novak, 2016; 
Glavas et al., 2007; Haynes et al., 1999; Li, Zheng, Wilsey, & Scarpace, 2004; Skibicka & 
Gril, 2009; Song et al., 2008; Strader et al., 2007; Wiliams et al., 2003; Yasuda, Masaki, 
Sakata, & Yoshimatsu, 2004). Convincingly, and similarly to PACAP, the melanocortin 
system is also deemed essential for the thermogenic response in BAT. 
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Both PACAP and MCRs are colocalized in the VMN; one of the key hypothalamic 
nuclei thought to be involved in activation of BAT thermogenesis (introduced in Chapter 1 
and discussed in detail in Chapter 3) (Bartness, Vaughan, & Song, 2010; Hawke et al., 2009; 
Nakata et al., 1999). Upon stereotaxic MTI injections into the VMN, similar results were 
observed to those with pharmacological injections of PACAP into the VMN: an increase in 
energy expenditure and thermogenesis (Gavini, Jones, & Novak, 2016). These results suggest 
that PACAP and the melanocortin system share a common pathway in activating BAT 
thermogenesis, however; while considerable amounts of literature exist for the crucial role of 
PACAP and the melanocortin system in BAT thermogenesis individualy, very litle evidence 
exists connecting the two. Of the limited existing evidence for the connection between 
PACAP and the melanocortin system in energy intake, available literature suggests that 
PACAP acts upstream from the melanocortin-dependent pathway to inhibit food intake (Dür 
et al., 2007; Iemolo, Feragud, Cotone, & Sabino, 2015; Mounien et al., 2008). Similarly, the 
sole piece of literature that exists for the connection between PACAP and the melanocortin 
system in energy expenditure also suggests that PACAP acts upstream from the melanocortin 
system in activating BAT thermogenesis (Tanida, Shintani, & Hashimoto, 2011). As 
described in Chapter 1, researchers ilustrated this connection by performing ICV injections 
of a MC4R antagonist folowed by PACAP, and compared the neural response in BAT to 
those without the antagonist injection (Tanida, Shintani, & Hashimoto, 2011). Without the 
antagonist, PACAP injections showed increased neural activity to BAT. However, when the 
MC4R antagonist was injected prior to PACAP, negligible sympathetic nerve activity was 
observed at the level of BAT, suggesting that PACAP acts upstream of the melanocortin 
system in activating BAT (Tanida, Shintani, & Hashimoto 2011). Further research is 
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necessary to support (or refute) these results, which has been conducted here in the Gray lab 
and described in this chapter.  
Hypothesis and Aims 
We hypothesize that PACAP acts upstream from the melanocortin system to regulate 
SNA to stimulate adaptive thermogenesis in BAT (Figure 2.2). 
The objectives of this chapter are: 
• To determine if the impaired thermogenesis in PACAP -/- mice can be 
rescued pharmacologicaly with a melanocortin agonist, Melanotan I (MTI), 
and thus provide evidence using a genetic model of PACAP deficiency for the 
connection between PACAP and the melanocortin system in regulating 
thermogenesis in BAT 
To address the hypothesis and aims, thermogenic capacity was evaluated through 
physiological (body weight and composition, metabolic rate (open circuit calorimetry), and 
respiratory exchange ratio (RER), molecular (thermogenic gene expression), and 
histological (lipid area and cel count) analyses. Complete materials and methods are 
described in detail below.  
2.2 MATERIALS AND METHODS 
Animals 
Adult, female mice (aged 2-5 months) were generated from a breeding colony of 
PACAP nul mice at the University of Northern British Columbia. Mice used in this study 
were derived from the PACAP nul line generated by Gray et al. (2001) and were of mixed 
genetic background (C57BL/6-129/SvJ). Genotypes were determined prior to experiments 
via an established polymerase chain reaction (PCR) genotyping reaction, described below 
(Gray et al., 2002). Briefly, pups were ear-clipped in order to provide a tissue sample for 
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Figure 2.2. Proposed pathways of interaction for adaptive thermogenesis in BAT in response to cold 
exposure. VMN; ventromedial nucleus, PACAP; pituitary adenylate cyclase-activating polypeptide, 
MC; melanocortin system, SNA; sympathetic nerve activity, BAT; brown adipose tissue. Images 
adapted from “Revisiting the Ventral Medial Nucleus of the Hypothalamus: The Roles of SF-1 
Neurons in Energy Homeostasis”, by Y. Choi, T. Fujikawa, J. Lee, A. Reuter, & K. Kim, 2013, 
Frontiers In Neuroscience, 7. Copyright © 2013 Choi, Fujikawa, Lee, Reuter and Kim. Adapted with 
permission from author. 
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DNA extraction as wel as for animal identification. Genomic DNA was extracted from the 
ear clip tissue sample using a solution of 10% Chelex (Bio-Rad Laboratories, Inc., Hercules, 
CA) with proteinase K and 10% Tween 20. The reaction was incubated at 50°C for 45 
minutes, folowed by 15 minutes at 95°C to inactivate the proteinase K. The solution was 
mixed and the Chelex was alowed to setle to the botom of the tube. Genomic DNA (2 µl) 
was then added to a 20-µl PCR reaction containing 0.25 µl Taq polymerase (Thermo Fisher 
Scientific, Waltham, Mass.), 10 × New England Biolabs PCR bufer, 10 µM deoxynucleoside 
triphosphates (dNTPs), and 10 µM of three primers: 5′MP1 (5′ ATG TGT AGC GGA GCA 
AGG CTG G 3′), 5′MP2 (5’ GAA CAC GAG TGA TGA CTG GTC AGT C 3’), and PA1 (5′ 
CAC TCG CAC GGC ATC TTC ACA GAT AG 3′). The reaction conditions were: 
denaturation at 94°C for 5 min folowed by 94°C for 30 sec; annealing at 67°C for 30 sec; 
extension at 72°C for 30 sec for 32 cycles and a long extension at 72°C for 7 min. PCR 
reaction products were run on an ethidium bromide stained 1.5% agarose gel and visualized 
under ultraviolet (UV) light. The genotypes of the mice were classified by visualized bands: 
the wild-type alele produced a band of approximately 550 base pair (bp), whereas the 
knockout alele produced a band of approximately 950 bp (Appendix Figure S2.1). Water, 
rather than genomic DNA, served as a negative control for PCR reactions. 
Using four cohorts, a total of 32 mice were generated for this study. PACAP +/+ 
(n=16) and PACAP -/- (n=16) litermate mice were housed in pairs, with one PACAP +/+ 
and one PACAP -/- per cage with a standardized amount of nesting material (1 square/cage) 
and corn cob bedding to control for the amount of bedding material that could be used as a 
thermogenic substrate. Throughout the experiment, the mice were exposed to a normal 12 h 
light:12 h dark cycle (lights on 0700–1900 h) and had free access to water and standard 
rodent chow diet (LabDiet 5001, LabDiet, Inc., Brentwood, Leduc, AB, Canada; 
 47 
metabolizable energy 3.02 kcal/g). Mice were weighed twice weekly and cages changed 
twice weekly. The care and treatment of the mice was in accordance with the guidelines of 
the Canadian Council on Animal Care, and protocols were approved by the University of 
Northern British Columbia’s Animal Care and Use Commitee. 
Cold Acclimation and Melanotan II treatment 
Female mice (PACAP +/+ (n=16), PACAP -/- (n=16) were acclimated to 4°C by 
initialy being moved in their home cages from 24°C to 18°C for 7 days and then to 4°C for 
30 days (Figure 2.3). This timeframe was selected as ful acclimation to cold and maximal 
induction of adaptive thermogenesis requires 3-4 weeks at 4°C (Cannon & Nedergaard, 2010; 
Meyer et al., 2010; Ukropec et al., 2006).  
After 7 days of acclimation in 4°C, the mice were given daily intraperitoneal (IP) 
injections (alternating injection site on left and right sides every 3 days) of either phosphate-
bufered saline (PBS) as the vehicle (1xPBS, 0.12ml) or Melanotan I (MTI, 0.4mg/kg in 
0.12ml 1xPBS) for 23 days. PACAP +/+ (n=9) and PACAP -/- mice (n=9) received PBS, and 
PACAP +/+ (n=7) and PACAP -/- mice (n=7) received MTI. During the day of calorimetry, 
injections were not given. Throughout this paper, PACAP +/+ mice wil be refered to as 
wildtype (WT) and PACAP -/- as knockout (KO). Thus, four treatment groups exist and wil 
be refered to as the folowing: PBS WT, PBS KO, MTI WT and MTI KO. 
Body Composition 
Body composition was measured pre- and post-treatment using time-domain nuclear 
magnetic resonance (TD-NMR). Unanaesthetised mice were individualy placed in a 
restrainer with access to oxygen and then placed in the minispec mq TD-NMR machine for 
two minutes while measurements of total body fat, fluid, and lean mass were obtained 
(minispec mq, TD-NMR, Bruker, CA). The fat and lean masses were calculated as a 
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Figure 2.3. Schematic of methodology over the course of the 6-week experiment.  
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percentage of total body mass, and the pre- and post-treatment fat and lean mass percentages 
were calculated. 
Thermogenic Capacity through Oxygen Consumption 
On day 21 of treatment, oxygen consumption of the mice was individualy measured 
by open circuit calorimetry (Oxymax machine, Columbus Instruments, Columbus, OH, 
USA). The single-mouse Oxymax housing chamber was equilibrated for two hours before 
basal oxygen consumption was measured in the animals. Animals were anesthetised with 
sodium pentobarbital (50-60mg/kg, ip). Once a plane of anesthesia was reached, the 
interscapular region was shaved and disinfected with 90% isopropyl alcohol. A cannula was 
inserted subcutaneously over the interscapular BAT to	alow for the administration of NE 
later in the experiment while avoiding opening the chamber. The mice were then placed into 
the Oxymax chamber for 10 minutes to alow for equilibration of the machine. The animals 
then spent approximately 15 minutes in the chamber to alow for basal metabolic rate (BMR) 
(defined below) to be recorded. After oxygen consumption readings were stable, NE 
(1mg/kg, sc) was injected over the BAT of the mice via the cannula and oxygen consumption 
was measured for approximately one hour until the maximal metabolic rate (MMR) occured, 
as determined by a peak in oxygen consumption folowed by a steady decline in oxygen 
consumption. BMR was defined as the mean of the five lowest oxygen consumption values 
prior to the NE injection. MMR was defined as the mean of the five highest oxygen 
consumption values after NE administration. Oxygen consumption values were recorded 
every 10 seconds and were then calculated and reported as an average reading over 2 
minutes, beginning 10 minutes prior to NE injection and ending approximately 34 minutes 
post NE injection. Oxygen consumption values from the Oxymax software were normalized 
to each animal’s pre-treatment lean mass (ml/min/kg lean mass). Respiratory exchange ratio 
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(RER) is a calculated ratio between the volume of carbon dioxide (VCO2) produced and 
oxygen (VO2) used (VCO2/VO2) and represents a measure of which macronutrient (fat or 
carbohydrate) is oxidized for fuel utilization (Gavini, Jones, & Novak, 2016). As with 
oxygen consumption value, RER values were recorded every 10 seconds and were then 
calculated and reported as an average reading over 2 minutes, beginning 10 minutes prior to 
NE injection and ending approximately 34 minutes post NE injection. 
Post-mortem Analysis 
Upon completion of the 23-day treatment, the non-fasted mice were weighed and 
deeply anesthetized with isoflurane. Blood was colected into heparinized tubes by cardiac 
puncture (approx. 0.7-1.0 ml/mouse) and spun down at 3,000 rpm for 10 minutes and plasma 
colected. The mice were then euthanized with isoflurane and cervical dislocation. Tissues 
weighed and colected included BAT, inguinal and gonadal white adipose tissue (ingWAT, 
gWAT), liver and pancreas. These tissues, in addition to skeletal muscle, smal intestine, 
kidney, heart and lungs were flash frozen in liquid nitrogen and stored in -80°C. Tissues 
fixed in 10% formalin included BAT, ingWAT, gWAT, skeletal muscle, kidney, pancreas, 
and adrenal glands. The brain was colected, frozen and stored at -80°C.  
RNA Extraction and cDNA generation 
RNA extractions were performed on frozen samples of BAT, ingWAT and gWAT. 
Tissues (0.05-1g) were homogenized in TRIzol (Life Technologies) and RNA was extracted 
according to the manufacturer’s protocol, using the additional optional process for samples 
with high fat content provided. TURBO DNase (Life Technologies) was used in accordance 
with the manufacturer’s protocol to remove DNA contamination. RNA concentration and 
purity were evaluated through UV light absorbance measurements using spectrophotometry 
(Nanodrop ND-1000; Thermo Scientific, Rockford, IL, USA). Absorbance levels of the 
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sample at 260nm were used as a surogate measure of RNA concentration (the wavelength at 
which nucleotides absorb UV light). The ratio of absorbance at 260nm and 280nm (the 
wavelength at which protein absorbs UV light) was used to assess the purity of RNA, where 
a ratio of ~2.0 is generaly accepted as “pure” for RNA. As a secondary measure of nucleic 
acid purity, the ratio of absorbance at 260nm and 230nm was used to identify the presence of 
contaminants that absorb at 230nm, such as phenol present in the TRIzol reagent used during 
RNA extractions. 260/230 values commonly range between 2.0-2.2 for “pure” nucleic acid. 
RNA integrity was assessed by observing intact, bright and distinct 18S and 28S rRNA bands 
on ethidium bromide stained 1.5% agarose gels (Appendix Figure S2.2). RNA (500ng) was 
reverse transcribed into cDNA (Superscript II, Invitrogen) with a blend of oligo(dT) and 
random hexamer primers according to the manufacturer’s protocol. 
Gene Expression 
BAT thermogenic gene expression (β3-AR, HSL, and UCP1), one control gene (β1-
AR), and six reference genes (18S, TBP, GAPDH, PGK1, RPL19, and PPIA) were assessed 
using quantitative real-time polymerase chain reaction (qPCR). 15 µl reactions were caried 
out using an iQ5 thermocycler (Bio-Rad Laboratories) and contained forward and reverse 
primers (1 µM; Sigma), nuclease-free H2O, 1/10 cDNA (1.5 µl), and SYBR Green Supermix 
(1X). Primers used in this experiment had been previously optimized in the Gray lab (by 
Daemon Cline) and conformed to the Minimum Information for Publication of Quantitative 
Real-time PCR Experiments (MIQEs) guidelines (Bustin et al., 2009). A measure of 
reference gene stability (M) across genotypes and treatments was determined with Biogazele 
(Biogazele qBasePlus 2.4, Zwijnaarde, Belgium) where reference genes with M < 0.5 were 
accepted. Two reference genes (RPL19 and PPIA) were selected for each gene expression 
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analysis (M = 0.26). Fold change in gene expression was calculated for each gene, in each 
group, as compared to expression from PBS WT animals.  
Histology 
Formalin-fixed tissues were sent for histological sectioning (Wax-It Histological 
Services, UBC, Vancouver, Canada): BAT, ingWAT, and gWAT (PBS WT (n=4), PBS KO 
(n=4), MTI WT (n=4), MTI KO (n=4). Tissues were parafin embedded, sectioned (5 µm 
thick), and stained with hematoxylin and eosin for viewing on a light microscope (Olympus 
BX61). Analyses were completed for BAT and gWAT in conjunction with an undergraduate 
honours thesis (in colaboration with Maeghan Forster).  
Histological Micrographs 
Histological analyses performed in this study were recently developed by UNBC 
Gray lab members and have not been previously documented in our research. Therefore, 
control animals with wel-documented diferences in the histological presentation of BAT 
were initialy analyzed (thermoneutral (30°C) versus cold stressed (4°C) animals; results not 
shown or discussed). Results using this newly developed protocol were consistent with those 
documented in the literature, thus ensuring the validity of the protocol for experimental 
analyses.  
Ten micrographs of BAT were taken (Olympus BX61) per mouse (n = 4 mice per 
treatment) at 60x magnification using an oil immersion objective within three tissue sections 
(3 tissue sections/slide). Tissue sections used for the micrographs were selected randomly, 
however, care was taken to avoid field of views that contained large blood vessels, damaged 
cels, or heterogeneity among cel types to ensure proper representation of adipocytes. 
Three micrographs of gWAT were taken (Olympus BX61) per mouse (n = 4 mice per 
treatment) at 20x magnification. In cold-acclimated PBS WT and MTI WT mice, 
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micrographs were taken using the same methodology for BAT with respect to random 
selection described above. In contrast, homogenous gWAT areas were selectively chosen in 
cold-acclimated PBS KO and MTI KO mice due to a high degree of unexpected beige 
adipocytes within the gWAT sections, which left very few areas with large enough regions of 
white adipocytes. 
BAT Lipid Area 
CelSens Software (Olympus) was used in al preparation and analysis of lipid area 
measurements of BAT. Images were converted from bright field to grayscale (Figure 2.4A), 
and contrast was maximized before analyses to distinguish black from white (Figure 2.4B). 
In grayscale adipocyte histology, lipid area and intracelular spaces appeared “white,” while 
cel membranes, nuclei, and blood cels appeared as diferent shades of “grey.” Micrographs 
were further edited by selectively deleting areas that were not homogeneous representatives 
of brown adipose cels, such as large intracelular spaces, blood vessels, or erythrocytes 
(Figure 2.4C). Deleting an object from the region of interest (ROI) also removed that area 
from the total ROI for future area percentage calculations. A manual intensity threshold was 
set that best represented the “grey” regions, which represented non-lipid areas of each of the 
cross section (gray channel: min = 0, max = 172). These “grey” areas were quantified after 
segmenting the micrographs into binary photos (Figure 2.4D), and then measuring area for 
each colour (white or grey). Results were normalized to their respective ROI area per photo 
(excluding deleted regions) by converting to percentages, and subtracted from 100 to give 
total lipid (“white”) area per micrograph. 
BAT Cel Count 
Cel count per field of view in BAT was performed by individualy counting the 
number of nuclei in each image, providing a surogate measure of overal cel size between  
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Figure 2.4. Methodological steps used to analyze BAT sections for lipid area at 60x oil immersion. 
A. Images were converted to grayscale. B. Contrast was maximized. C. Segments that were not 
brown adipocytes were selectively deleted (indicated as red). D. Image was binarized and “white” 
area counted as lipid. 
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treatment groups. To increase counting accuracy, a 4-segment grid was laid over each image 
(Microsoft Powerpoint). Nuclei counts of each quarter segment of a photo were added 
together to give one count per image. Average number of cels in a field of view was then 
calculated. 
gWAT Cel Area Binning 
To determine the distribution of diferent white adipocyte sizes in gWAT, CelSens 
Software (Olympus) was used to measure the area of white adipocytes in images taken using 
a 20x objective. Images were prepared for analysis by converting them to grayscale (Figure 
2.5A) folowed by maximizing contract using a diferential contrast enhancement filter (Band 
Width = 35, Enhancement = 100, Overflow = 0.05%) (Figure 2.5B). Subsequently, images 
were binarized to separate lipid (white) from non-lipid areas (grey) (Figure 2.5C) (Grey 
channel: min = 0, max = 213). Cel boundaries were then split automaticaly by the CelSens 
software, folowed by manual spliting for cels that contained very thin cel membrane 
staining and were thus missed by automated spliting. Cels along the outer micrograph edges 
that did not display the entire cel circumference were deleted (Figure 2.5D). An average of 
the largest and smalest cel areas across micrographs was calculated to determine a range for 
adipose cel size binning analysis (Min: 80µm2, Max: 2000µm2). Object sizes too large or too 
smal to represent adipocytes were excluded as they likely represent artifacts of graininess or 
large intracelular spaces within a micrograph. Area data was exported to Excel and sorted 
from largest to smalest. Cel areas were sorted into bins based on cel area (in µm2: 80-499, 
500-999, 1000-1499, 1500-2000). Only the gWAT of cold-acclimated PBS and MTI treated 
PACAP WT mice were statisticaly analyzed due to the unexpected observation of an 
immense amount of beige adipocytes in gWAT of cold-acclimated PBS and MTI treated 
PACAP KO mice. 
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Figure 2.5. Methodological steps used to determine cel area counts in histological sections of gWAT 
imaged at 20x. A. Images were converted to grayscale. B. Differential contrast was maximized. C. 
Images were binarized. D. Adipocytes not entirely displayed within the field of view were excluded 
from analyses. 
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Statistical Analyses 
Results were expressed as group mean ± standard eror mean (SEM). Two-way 
ANOVA was used to determine mean diferences between treatment groups (cold-acclimated 
PBS WT, PBS KO, MTI WT, and MTI KO mice), where interactions between two 
independent variables may influence the dependent variable. The independent variables were 
time and treatment group, and the dependent variable was one of the folowing: body mass, 
body composition, oxygen consumption, or RER. One-way ANOVA with Tukey’s test for 
pairwise comparisons was used for comparisons between al four treatment group means and 
were performed for gene expression, BAT lipid area, and BAT cel count. Unpaired t-tests 
were used to analyze mean diferences between tissue masses for cold-acclimated PBS WT 
and cold-acclimated PBS KO mice, as wel as cold-acclimated PBS WT and cold-acclimated 
MTI KO mice. Unpaired t-tests were also used for the number of ingWAT cels within each 
cel size bin between cold-acclimated PBS WT and cold-acclimated MTI WT mice. The 
detection of outliers was determined using Grubb’s test. Results were considered statisticaly 
significant using an alpha of 0.05. Statistical analyses were performed using GraphPad Prism 
Software, version 6.0b. 
2.3 RESULTS 
Analyses Between Diferent Genotypes and Treatments 
 This study examined the efect and interaction of both PACAP genotype and 
melanocortin agonist treatment on thermogenic capacity in mice and thus, as described 
above, we present here results for 4 groups of cold-acclimated animals: PBS WT, PBS KO, 
MTI WT and MTI KO. Comparisons between cold-acclimated MTI WT and PBS KO are 
not reported, as they are not physiologicaly relevant; cold-acclimated MTI WT animals 
were used to determine the efects of MTI on WT animals (if any) to ensure proper analysis 
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of MTI KO animals. Although no significance was observed in any result between cold-
acclimated PBS WT and MTI WT, the trends that did exist wil be discussed and suggest 
that, as expected MTI may have had some physiological efect on cold-acclimated WT 
animals, and thus alowed us to confidently assess the cold-acclimated MTI KO animals.  
Comparisons between cold-acclimated PBS KO and MTI KO mice (or between cold-
acclimated MTI WT and MTI KO mice) were also not the focus of these analyses (but wil 
be discussed where appropriate) as we aimed to determine if MTI KO mice were rescued 
back to physiological normal levels (as compared to cold-acclimated PBS WT animals). 
Therefore, changes in the diferences between cold-acclimated PBS WT and PBS KO mice 
versus cold-acclimated PBS WT and MTI KO mice wil be the focus of the analyses.  
MTII Treatment Caused No Significant Efect on Body Weight or Body Composition 
No significant diference in body weight or body composition was observed between 
cold-acclimated PBS WT, PBS KO, MTI WT or MTI KO animals (two-way ANOVA, p > 
0.05) (Figure 2.6, Figure 2.7). 
MTII Partialy Rescues Diminished gWAT Depot in Cold-Acclimated PACAP KO Mice 
As expected from previously published results, there was a significant decrease in 
gWAT mass in cold-acclimated PBS KO mice compared to cold-acclimated control mice, 
PBS WT (unpaired t-test, p < 0.05) (Figure 2.8) (Adams et al., 2008; Diané et al., 2014). This 
significance was not observed between cold-acclimated PBS WT and MTI KO (unpaired t-
test, p > 0.05). Similar trends were observed in both ingWAT and BAT, but no significance 
was identified (Figure 2.8). 
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Figure 2.6. Body mass of PBS WT, PBS KO, MTII WT, and MTII KO mice over the course of the 
experiment. Treatment with vehicle (PBS) or MTII began on Day 7. Data are mean ± SEM. Two-way 
ANOVA, p > 0.05. 	
 
	Figure 2.7. Difference of fat and lean mass as a percentage of total mass in PBS WT, PBS KO, MTII 
WT, and MTII KO mice pre and post 4°C cold chalenge. Data are mean ± SEM. Two-way ANOVA, 
p > 0.05. 	
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Figure 2.8. Percent tissue mass per total body mass of different tissue types in PBS WT, PBS KO, 
MTII WT, and MTII KO mice after 4-week 4°C cold chalenge. Data are mean ± SEM. Unpaired t-
tests. *p < 0.05 indicates a genotype effect within the same treatment. 
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MTII Partialy Rescues Impaired Thermogenic Capacity of Cold-Acclimated PACAP 
KO Mice 
To test the hypothesis that PACAP acts upstream of the melanocortin system, the 
efect of the melanocortin agonist, MTI (0.4mg/kg, 23 days) on thermogenesis in cold-
acclimated PACAP WT and PACAP KO mice was evaluated first through oxygen 
consumption as a measurement of thermogenic capacity. Although no significance was 
observed between cold-acclimated PBS WT and PBS KO or cold-acclimated PBS WT and 
MTI KO, a trend showed cold-acclimated PBS WT achieving higher oxygen consumption 
values than cold-acclimated PBS KO, while cold-acclimated MTI KO values trended higher 
than cold-acclimated PBS KO (two-way ANOVA, p > 0.05) (Figure 2.9A). Additionaly, 
while no diference was observed in BMR between al four groups (two-way ANOVA, p > 
0.05), as previously reported by the Gray lab, there was a significant diference in MMR 
between cold-acclimated PBS WT and PBS KO mice (two-way ANOVA, p < 0.05) (Figure 
2.9B) (Diané et al., 2014). This significance was lost between cold-acclimated PBS WT and 
MTI KO mice (two-way ANOVA, p > 0.05) (Figure 2.9B). 
MTII Partialy Rescues Impaired Fuel Usage in Cold-Acclimated PACAP KO Mice 
Respiratory exchange ratio (RER), a measure of which macronutrient (fat or 
carbohydrate) is metabolized for fuel utilization, was calculated from Oxymax data as a ratio 
of VCO2 to VO2 and showed that, as expected, the administration of NE induced a decrease 
in RER in both cold-acclimated PBS WT and MTI WT mice, indicating preferential 
oxidation of lipids over carbohydrates folowing adrenergic stimulation (Figure 2.10). 
Previously, the Gray lab has shown that cold-acclimated PACAP KO mice do not experience 
this shift in RER with adrenergic stimulation: a finding that was repeated in this study, where 
RER in cold-acclimated PBS KO mice remained steady at ~0.85 after the NE injection. 
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A.	
B. 	
		
Figure 2.9. A. Norepinephrine induced thermogenesis in cold-acclimated PBS WT, PBS KO, MTII 
WT, and MTII KO mice. B. Mean basal metabolic rate (BMR) and maximal metabolic rate (MMR) 
of cold-acclimated PBS WT, PBS KO, MTII WT, and MTII KO mice. Data are expressed as mean ± 
SEM. Two-way ANOVA. *p < 0.05 indicates a genotype effect within the same treatment. 
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 Figure 2.10. Respiratory exchange ratio (RER) of cold-acclimated PBS WT, PBS KO, MTII WT, and 
MTII KO mice. Statistical significance (p < 0.05) between PBS WT and PBS KO at 8 and 10 minutes 
and between MTII WT and MTII KO at 2, 4 and 6 minutes. Two-way ANOVA.  
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Interestingly, cold-acclimated MTI KO mice showed a decrease in RER representing 
a preference toward lipid utilization folowing adrenergic stimulation, as observed in cold-
acclimated PBS WT mice (Figure 2.10). Statistical significance was exhibited between cold-
acclimated PBS WT and PBS KO at 8 and 10 minutes and between cold-acclimated MTI 
WT and MTI KO at 2, 4 and 6 minutes (two-way ANOVA, p < 0.05). 
No Diference in Thermogenic Gene Expression was Observed in BAT Between Cold-
Acclimated PBS or MTII Treated PACAP WT or PACAP KO Mice 
 No significant diference was observed between cold-acclimated PBS WT, PBS KO, 
MTI WT, or MTI KO mice for thermogenic gene expression of β3-ARs, HSL and UCP1 
(one-way ANOVA, p > 0.05) (Figure 2.11). β1-AR expression, used as a control to ensure 
MTI efects were localized to pathways involved in thermogenesis, was also not 
significantly diferent between groups (one-way ANOVA, p > 0.05) (Figure 2.11). 
No Significant Diference Between Lipid Area or Cel Size in BAT of Cold-Acclimated 
MTII WT and MTII KO Mice 
 Although no significant diference in lipid area between cold-acclimated PACAP WT 
or PACAP KO mice treated with either PBS or MTI was observed (one-way ANOVA, 
Tukey’s Test, p > 0.05) (Figure 2.12A), a trend indicated that both cold-acclimated MTI WT 
and MTI KO animals displayed greater lipid area per ROI compared to cold-acclimated PBS 
WT and PBS KO mice.  
 In agreement with these results, no significant diference in the number of cels per 
field of view between cold-acclimated PACAP WT or PACAP KO mice treated with either 
PBS or MTI was observed (one-way ANOVA, Tukey’s Test, p > 0.05) (Figure 2.12B). 
However, a trend indicated that both cold-acclimated MTI WT and MTI KO animals 
displayed fewer numbers of cels per ROI compared to cold-acclimated PBS WT and PBS 
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Figure 2.11. Gene expression in BAT of cold-acclimated PBS WT, PBS KO, MTII WT, and MTII 
KO mice. Target gene expression was normalized to two reference genes: RPL19 and PPIA. Data are 
expressed as ± SEM. One-way ANOVA for each gene, p > 0.05. 
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A. 
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Figure 2.12. A. Average percent lipid area/field of view in cold-acclimated PBS WT, PBS KO, MTII 
WT, and MTII KO mice. B. Average numbers of nuclei per ROI in cold-acclimated PBS WT, PBS 
KO, MTII WT, and MTII KO mice. Data are expressed as ± SEM. One-way ANOVA, p > 0.05. 
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KO mice. 
MTII WT Mice Display Increased Number of Smal White Adipocytes Compared to 
PBS WT Mice 
There was no significant diference between the number of white adipocytes within 
each cel size bin between cold-acclimated PACAP WT animals treated with PBS or MTI 
(unpaired t-test, p > 0.05) (Figure 2.13). However, a trend showed cold-acclimated MTI WT 
mice had higher numbers of smal cels (80-900µm) than those in cold-acclimated PBS WT 
mice. The analyses were not completed for cold-acclimated PBS KO or MTI KO animals 
due to unexpected heterogeneity of adipocyte types (brown or beige adipocytes) within the 
gWAT of cold-acclimated PACAP KO animals (discussed below).  
Cold-Acclimated PACAP KO Mice Have Extensive Browning Within Their gWAT 
Depot 
Cold-acclimated PBS WT and MTI WT displayed homogeneous gWAT composed 
of characteristic unilocular white adipocytes with isolated, smal regions of mild browning 
(Figure 2.14A, C). In contrast, histological sections of gWAT in cold-acclimated PBS KO 
and MTI KO revealed extensive multilocular adipocytes (beige or brown) within the WAT 
sections (Figure 2.14B, D). Browning was so extensive in gWAT samples of al cold-
acclimated PACAP KO mice examined (n = 7), that it was not possible to obtain three 
images comprised predominantly of unilocular, white adipocytes.  
2.4 DISCUSSION  
In response to cold exposure, literature shows PACAP KO mice exhibit impaired 
thermogenic capacity compared to PACAP WT mice, indicated by both physiological and 
molecular detriments (Adams et al., 2008; Diané et al., 2014; Gray et al., 2001; Gray et al., 
2002). Physiological impairments previously observed in cold-acclimated PACAP KO mice  
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Figure 2.13. Number of cels within each cel area bin (µm2) in cold-acclimated PBS WT or 
MTII WT mice. Data are expressed as ± SEM. Unpaired t-tests, p > 0.05. 
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Figure 2.14. Representative images of hematoxylin and eosin-stained gWAT observed at 4x and 20x 
in cold-acclimated PBS WT (A), PBS KO (B), MTII WT (C), and MTII KO mice (D). 
PBS WT (4x) PBS WT (20x) 
PBS KO (4x) PBS KO (20x) 
MTII WT (4x) MTII WT (20x) 
MTII KO (4x) MTII KO (20x) 
A. 
B. 
C. 
D. 
200 µm 50 µm 
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and documented in the published literature include: decreased adaptive thermogenesis in 
response to cold stress as measured by decreased NE-induced oxygen consumption, an 
inability to utilize lipid as the primary fuel source in response to sympathetic stimulation, and 
decreased white adipose tissue mass compared to PACAP WT mice (Diané et al., 2014; Gray 
et al., 2002). Notably, these results have been replicated here in cold-acclimated PACAP KO 
mice (PBS KO mice), although not to the same degree as indicated in previously published 
studies, possibly due to the diferent genetic background of the PACAP nul mouse line used 
between studies (discussed below) (Figure 2.9, 2.10, and 2.8, respectively). Furthermore, in 
this study, al three observed physiological impairments were partialy rescued in cold-
acclimated PACAP KO mice treated with MTI (MTI KO mice), as indicated by 
intermediate phenotypes in this group compared to cold-acclimated PBS-treated PACAP WT 
(PBS WT mice) (Figure 2.8, 2.9, and 2.10). Each of these findings wil be discussed here in 
detail. 
Importantly, NE-induced oxygen consumption is a measure of adaptive 
thermogenesis in BAT, a process that is imperative in maintaining homeostasis of body 
temperature in response to cold exposure or feeding (Cannon & Nedergard, 2004; 
Nedergaard & Lindberg, 1979). When BAT is absent or functionaly deficient, one 
mechanism by which the body atempts to control body temperature is via skeletal muscle 
oxidation through shivering or increased physical activity (Grubb & Folk, 1976; Schaefer, 
Vilarin, & Lindstedt, 2003; Shiota & Masumi, 1988). Therefore, in order to ensure the 
measurements of NE-induced oxygen consumption reflected the thermogenic capacity of 
BAT to perform adaptive thermogenesis, rather than increased muscle activity, oxygen 
consumption measurements were performed on anesthetized animals. The lower oxygen 
consumption values observed in cold-acclimated PBS KO mice as compared to cold-
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acclimated PBS WT mice (Figure 2.9) therefore confirms impaired BAT activity in PACAP 
KO mice: a result previously observed (Diane et al., 2014). Interestingly, NE-induced oxygen 
consumption measurements increased in cold-acclimated MTI KO mice as they displayed 
oxygen consumption levels higher than those of cold-acclimated PBS KO mice. Although, 
cold-acclimated MTI KO mice did not exhibit improvements in adaptive thermogenesis to 
levels observed in geneticaly unaltered cold-acclimated PBS WT mice, an intermediate 
phenotype was observed (Figure 2.9). This intermediate phenotype was observed over time, 
as indicated in the oxygen consumption curve (Figure 2.9A), and was further supported with 
the calculated MMR (Figure 2.9B), suggesting a partial rescue of the impaired BAT activity 
in cold-acclimated PACAP KO mice with MTI treatment. 
A previously published study showed increased spontaneous locomotor activity in 
PACAP KO mice compared to control WT mice, while other studies showed increased 
skeletal muscle activity and oxidative consumption capacity in cold-acclimated animals with 
absent BAT (Grubb & Folk, 1976; Hashimoto et al., 2001; Molica et al., 2005; Schaeffer, 
Vilarin, & Lindstedt, 2003; Shiota & Masumi, 1988; Simonyan et al., 2001). Increased 
skeletal muscle activity was observed by increased muscle temperature where calories were 
presumably dissipated as heat energy, and increased NE turnover to skeletal muscle 
indicating increased sympathetic nerve activity to skeletal muscle (Nogueiras et al., 2007). 
Therefore, increased skeletal muscle activity may be a mechanism by which PACAP KO 
mice adapt to survive cold exposure when afronted with impaired adaptive thermogenesis 
(Grubb & Folk, 1976; Hashimoto et al., 2001; Molica et al., 2005; Schaefer, Vilarin, & 
Lindstedt, 2003; Shiota & Masumi, 1988; Simonyan et al., 2001).  
Altering fuel usage is another method of adaptation that is required for a response to 
environmental stressors such as cold exposure (Haman et al., 2002). Fuel sources include 
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carbohydrates, protein, and lipids (Haman et al., 2002). During prolonged cold exposure, 
muscle contractions receive the majority of their fuel from carbohydrates with a minor 
contribution from protein, whereas adaptive thermogenesis in BAT is fueled by FFAs derived 
from the breakdown of intracelular or circulating triglycerides (Figure 1.8) (Baba et al., 
2012; Haman et al., 2002; Ouelet et al., 2012). Because the oxidation of these 
macronutrients produce diferent quantities of CO2, calculating the ratio between the volume 
of CO2 and the volume of O2 (RER) as measured by indirect calorimetry is an indicator of 
which substrate is preferentialy oxidized for fuel utilization (Virtue & Vidal-Puig, 2013). 
RERs range from 0.7 (pure lipid oxidation) to 1.0 (pure carbohydrate oxidation) (Gavini, 
Jones, & Novak, 2016; Virtue & Vidal-Puig, 2013). Normaly, as observed in cold-
acclimated PBS WT control mice, RER drops towards lipid utilization (0.7) upon NE 
stimulation, as adrenergic stimulation promotes lipolysis of triglycerides to FFAs in WAT 
and BAT, providing substrate for adaptive thermogenesis in BAT (Figure 2.10) (Diane et al., 
2014). As previously published and shown here in these results, cold-acclimated PBS KO 
mice failed to display a drop in RER in response to NE and instead displayed a consistent 
RER over time with values closer to those indicative of carbohydrate use (Figure 2.10) 
(Diane et al., 2014; Nedergaard & Lindberg, 1979; Ouelet et al., 2012). This altered RER 
displayed in cold-acclimated PBS KO mice could indicate a dysfunction in lipid mobilization 
from adipose tissue, possibly due to a decreased ability to respond to NE, which is known to 
induce lipolysis in WAT and BAT (Chondronikola et al., 2016; Saito, Yoneshiro, & 
Matsushita, 2016).  
Interestingly, RER of cold-acclimated MTI KO mice folowed a similar trend to that 
of cold-acclimated PBS WT mice, suggesting a partial rescue of the altered fuel usage 
observed in PACAP KO mice with MTI treatment (Figure 2.10). Furthermore, cold-
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acclimated MTI WT mice displayed a trend in RER that decreased beyond values observed 
in cold-acclimated PBS WT mice (Figure 2.10); a result observed previously in the literature 
in rats treated with MTI at the level of the VMN (during both steady and increased physical 
activity) and consistent with the melanocortin system’s role in increasing lipid mobilization 
(Gavini, Jones, & Novak, 2016; Nogueiras et al., 2007). This observation was further 
supported in the histological examination of gWAT where a trend indicated cold-acclimated 
MTI WT mice displayed higher numbers of smal cels (80-900µm) than those in cold-
acclimated PBS WT mice (Figure 2.13), suggesting increased lipid mobilization with MTI 
treatment. 
PBS KO mice have been shown previously to display decreased WAT mass; a trend 
observed here in ingWAT (non-significant) and gWAT (significant) (Figure 2.8) (Diané et 
al., 2014). The reduced WAT depots in cold-acclimated PACAP KO mice may be related to 
the impaired NE-induced oxygen consumption observed in cold-acclimated PACAP KO 
mice. In a mouse model with severely reduced WAT mass (lipoatrophic A-ZIP/F-1, 
discussed in Chapter 1), mice treated with a β3 agonist did not display an increase in oxygen 
consumption, suggesting a key driver for NE-induced thermogenesis in the availability of 
fuel stores from adipocytes (Gavrilova, Marcus-Samuels, & Reitman, 2000). Therefore, 
impairments in WAT may lead to impairment of adaptive thermogenesis in BAT of PACAP 
KO mice, as FFAs released from triglyceride stores in WAT are a key substrate for lipid 
oxidation in adaptive thermogenesis (Chondronikola et al., 2016; Saito, Yoneshiro, & 
Matsushita, 2016). Supporting the intermediate phenotype of cold-acclimated MTI KO mice 
discussed above, treatment of cold-acclimated PACAP KO mice with MTI partialy rescued 
the decreased adipose tissue mass of cold-acclimated PACAP KO mice compared to cold-
acclimated PACAP WT mice (Figure 2.8). 
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Colectively, these physiological results show an intermediate phenotype displayed in 
cold-acclimated PACAP KO mice upon activation of the melanocortin system with MTI. 
Activation of the melanocortin system using this approach did not fuly restore the impaired 
physiological responses of the cold-acclimated PACAP KO mice to normal (as measured in 
control, cold-acclimated PBS WT mice) but provides preliminary evidence that supports the 
hypothesis that PACAP acts upstream of the melanocortin system in regulating SNA to 
stimulate BAT thermogenesis in response to cold exposure. Furthermore, these observations 
provide genetic support for the study described above and in Chapter 1 where Tanida, 
Shintani, & Hashimoto (2011) used a pharmacological intervention showing that PACAP 
signaling to BAT does not occur when a MC4R antagonist is used, thus suggesting PACAP 
acts upstream from the melanocortin system in activating SNA to stimulate thermogenesis.  
Molecular analyses of thermogenic gene expression were performed in order to refute 
or support the preliminary physiological improvements in thermogenesis observed in cold- 
acclimated PACAP KO mice with MTI treatment. However, of the 28 mice that underwent 
Oxymax experiments, 13 died either during or shortly after the experiment, possibly due to 
the inability to efectively regulate body temperature after prolonged anesthesia. As a 
consequence of the acute efects of NE stimulation on BAT, particularly on the genes 
involved in the mechanism of adaptive thermogenesis, only tissues from animals that lived 
until the day of dissection were used for qPCR thermogenic gene expression analysis 
(Cannon & Nedergaard, 2004). Due to the low sample sizes (particularly in cold-acclimated 
PBS KO (n = 3) and MTI KO (n = 4) mice), large standard eror (particularly in cold-
acclimated MTI KO mice), and inconsistent results compared to previously published 
literature, it was concluded that additional samples were necesary in order to confidently 
compare results of gene expression analysis between groups (Figure 2.11). 
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Histological analyses of BAT and gWAT were also performed to provide further 
evidence in support or opposition of the intermediate phenotype displayed in cold-acclimated 
PACAP KO mice upon activation of the melanocortin system with MTI. Although no 
significance was observed, histological analyses of BAT revealed a trend where both cold-
acclimated MTI WT and MTI KO exhibited greater lipid area and decreased number of 
cels compared to cold-acclimated PBS WT and PBS KO mice (Figure 2.12). Initialy, this 
result appeared to be contradictory to predicted results, where stimulating adaptive 
thermogenesis with MTI treatment would be expected to decrease lipid stores in BAT. 
However, upon further investigation as described above, this observation may be explained 
for cold-acclimated MTI WT mice by the alternative use of lipids from WAT to fuel 
adaptive thermogenesis in response to MTI treatment. This explanation was supported by 
the increased number of smal cels (80-900µm) in gWAT of cold-acclimated MTI WT mice 
compared to cold-acclimated PBS WT mice, consistent with previous literature (Figure 2.13) 
(Qian et al., 2013). The white adipocytes areas in gWAT of cold-acclimated MTI KO mice, 
however, were not analyzed due the extensive browning that was observed (Figure 2.14).  
Classicaly, gWAT contains homogeneous white adipocytes and functions as a major 
lipid storage depot and as insulation for organs (Giralt, & Vilaroya, 2013; van Beek et al., 
2015). Alternatively, the heterogeneity in ingWAT (not analyzed here) has been wel 
documented, where beige adipocytes appear within the WAT depot in response to cold 
exposure (Bartelt, & Heeren, 2013; Shabalina et al., 2013). This selective browning in WAT 
is thought to occur within subcutaneous WAT depots (such as ingWAT), as they are closer to 
the surface of the body and therefore expected to lose heat faster than internal WAT depots 
(such as gWAT) (Bartelt, & Heeren, 2013). Interestingly, gWAT in both cold-acclimated 
PBS KO and MTI KO mice displayed extensive browning, suggesting that in response to 
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impaired thermogenesis during cold exposure, yet another method of adaption may exist, in 
addition to increased skeletal muscle activity and altered fuel usage discussed above. 
Notably, the extent of the observed browning in gWAT in cold-acclimated PACAP KO mice 
has not been previously documented in the literature. Browning in gWAT has, however, been 
observed upon central administrations of thyroid hormones in the VMN, IP injections of a β3 
agonist, and stimulation of natriuretic peptides receptors (Kim et al., 2016; Martinez-Sanchez 
et al., 2016; Neinast et al., 2015; Weiner et al., 2016). Interestingly, these are known 
regulators of BAT thermogenesis described in Figure 2.1. 
Although not quantified, gWAT in cold-acclimated MTI KO mice appeared to 
contain fewer beige adipocytes compared to cold-acclimated PBS KO mice, suggesting less 
compensation by browning WAT in cold-acclimated PACAP KO mice with MTI treatment 
(Figure 2.13). Although this finding on its own does not provide enough evidence to support 
the partial rescue of impaired thermogenesis in cold-acclimated PACAP KO mice with MTI 
treatment, it does provide another piece of evidence to contribute to the physiological results 
discussed above that suggest PACAP acts upstream from the melanocortin system in 
regulating SNA to stimulate adaptive thermogenesis in response to cold exposure. Future 
quantifications of the amount of “browning” through molecular analyses could further 
support or refute the partial rescue of the impaired adaptive thermogenesis in cold-acclimated 
PACAP KO mice treated with MTI discussed above. 
Importantly, the genetic background of the mice should be considered when 
referencing previous literature to enable appropriate interpretation of the phenotypic 
expression of the specific genes (as mentioned above). The mice used in these experiments 
were of mixed genetic background (C57BL/6 and 129/SvJ), whereas mice used previously in 
the Gray lab were of pure genetic background (backcrossed onto a C57BL/6 background) 
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(Diané et al., 2014; Gray et al., 2002). As a result of extensive inbreeding, pure genetic 
backgrounds are geneticaly uniform, which alows for a more accurate evaluation of the 
observed phenotype (resulting from genetic manipulation) by eliminating phenotypic 
variations caused by mixed genetic backgrounds (Yoshiki & Moriwaki, 2006). As such, mice 
from pure genetic backgrounds are typicaly the gold standard used in transgenic research, 
which is why they were initialy used in the Gray lab. However, due to the complexity of the 
PACAP KO phenotype that resulted in high mortality rates, animal care and financial 
concerns were considered: because a large number of animals were required to provide 
suficient animal numbers for robust experiments and analyses, the decision to use mice with 
a mixed genetic background in order to improve PACAP KO pup survival and reduce colony 
numbers was made.  
Animals on a pure genetic background often display a more severe phenotype 
compared to those of mixed genetic background that display greater variability in the 
phenotype: a result that was observed here when comparing results derived in C57BL/6-
129/SvJ PACAP KO mice to previous literature, that used pure C57BL/6 PACAP KO mice 
(Doetschman, 2009; Yoshiki & Moriwaki, 2006). This phenomenon is particularly prevalent 
in mice with targeted mutations (KO animals) and may be due to modifier genes that 
influence gene expression through suppression or enhancement, alteration of DNA 
transcription, and epigenetic efects such as DNA methylation (Doetschman, 2009; Jackson 
Laboratory, 2006; Yoshiki & Moriwaki, 2006). Therefore, PACAP KO mice of mixed 
genetic background used here may have compensatory physiological mechanisms in response 
to cold exposure when compared to geneticaly pure PACAP KO mice, leading to a less 
severe phenotype. 
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Furthermore, controversy exists as to whether MTI is capable of crossing the blood 
brain barier (BBB), and it is imperative to take this into consideration as we suggest PACAP 
interacts with the melanocortin system centraly in the VMN of the hypothalamus (where 
both PACAP and melanocortins are expressed) when our methodological approach consisted 
of peripheral MTI injections (Glavas et al., 2007; Kim et al., 2000; Modi et al., 2015; 
Piggins et al., 1996; Trivedi et al., 2003). Notably, in addition to receptors located in the 
brain, MC4R mRNAs have been detected in peripheral tissues including skeletal muscle and 
adipose tissue, suggesting both central and peripheral action of the melanocortin system 
(Boston & Cone, 1996; Chagnon et al., 1997; Hoggard et al., 2004; Mountjoy et al., 2003). 
Interestingly, whether administered centraly or peripheraly, MTI elicits inhibitory efects 
on food intake and excitatory efects on energy expenditure, suggesting that either brain 
penetration is not required for MC4R agonists such as MTI to suppress food intake and 
increase energy expenditure, or, more likely, that the BBB is leaky, alowing MC4R agonists 
to cross at certain areas and act on central systems (Gavini, Jones, & Novak, 2016; Glavas et 
al., 2007; Hagan, Bolon, & Keene, 2012; Kievit et al., 2012; Trivedi et al., 2003). To further 
elucidate hypothalamic pathways between PACAP and the melanocortin system in activating 
BAT thermogenesis, therefore, central administration of MTI in cold-acclimated PACAP 
KO mice could be performed. This, however, first relies on the knowledge of which 
hypothalamic brain region PACAP acts to regulate thermogenesis. This is the major focus of 
Chapter 3 and wil be discussed in detail.  
In conclusion, activation of the melanocortin system with peripheral injections of 
MTI partialy rescues the impaired thermogenesis of cold-acclimated PACAP KO mice, 
providing preliminary evidence to support the hypothesis that PACAP acts upstream from the 
melanocortin system in regulating SNA to BAT to induce adaptive thermogenesis during 
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cold exposure. Future directions of this project include increasing sample size to more 
robustly measure gene and protein expression of thermogenic proteins in BAT, ingWAT, and 
gWAT depots. Additionaly, further histological analyses of adipose tissues to identify 
characteristics of thermogenicaly active adipose tissue, such as measuring lipid content and 
browning in ingWAT and gWAT depots wil be performed. These analyses wil help support 
or refute the partial physiological rescue of adaptive thermogenesis with MTI treatment of 
cold-acclimated PACAP KO mice described here.  
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2.6 APPENDIX 
   
Figure S2.1. PCR assessment of PACAP genotype in Mus musculus. Electrophoresis performed on 
ethidium bromide stained 1.5% agarose gel at 100V for 20 minutes. Each wel represents a different 
animal. (+/+) denotes PACAP wildtype, (+/-) PACAP heterozygote, and (-/-) PACAP knockout. 
 
 	
Figure S2.2. Assessment of RNA integrity of isolated Mus musculus brown adipose tissue (BAT) 
with electrophoresis on an ethidium bromide stained 1.5% agarose gel at 100V for 30 minutes. Each 
wel represents a different BAT sample. The top band indicates intact 28S rRNA and the botom band 
indicates intact 18S rRNA. 
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CHAPTER 3 
Creating a Viral Construct and Delivery Method for Genetic Intervention Aimed at 
Restoring Impaired Thermogenesis of PACAP -/- Mice 
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3.1 INTRODUCTION 
 As discussed in detail in Chapter 2, PACAP is essential for the normal thermogenic 
response of BAT as indicated by loss and gain of function experiments using both genetic 
and pharmacological interventions (Adams et al., 2008; Cummings, Pendlebury, Sherwood, 
& Wilson, 2004; Diané et al., 2014; Gray et al., 2001; Gray et al., 2002; Inglot, Farnham, & 
Pilowsky, 2011; Resch et al., 2011; Resch et al., 2013; Tanida et al., 2010). The mechanisms 
by which PACAP regulates body temperature and thus energy metabolism, however, remain 
unknown. Because the greatest physiological stimulus of adaptive thermogenesis in BAT is 
sympathetic nerve activation initiated at the level of the hypothalamus (discussed below), the 
evidence for PACAP’s central role in the brain wil be reviewed here, with the future aim of 
elucidating the specific hypothalamic mechanisms by which PACAP acts to regulate 
thermogenesis (Bamshad, Song, & Bartness, 1999; Bartness, Vaughn, & Song, 2010; Chechi, 
Carpentier, & Richard, 2013; Labbé et al., 2015; Saito, Yoneshiro, & Matsushita, 2016). 
 Briefly introduced in Chapter 1, the hypothalamus is composed of several distinct 
nuclei, including the ARC (discussed in Chapter 1), DMN, VMN, LHA and PVN (Figure 
1.5), and colectively integrates both central and peripheral signals of body energy status to 
regulate food intake and energy expenditure to appropriately maintain body weight and 
energy homeostasis (Rea, 2015). While PACAP and PACAP receptors are expressed in each 
of the nuclei named above, significantly higher expression levels occur in the VMN and the 
PVN (Arimura et al., 1991; Das, Vihlen, & Legradi, 2006; Hannibal et al., 2002; Hashimoto 
et al., 1996; Jolivel et al., 2009; Masuo et al., 1993; Segal et al., 2005; Sheward, Lutz, Copp, 
& Harmar, 1998). Although the functional role of certain hypothalamic nuclei are wel 
known (such as appetite regulation in the ARC), others have overlapping and even opposing 
functions, making it chalenging to discern the pathways regulating energy homeostasis. For 
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example, disinhibiting neurons of the DMN or the LHA with a GABA receptor antagonist 
resulted in increased thermogenesis as measured by increased core and BAT temperature, 
suggesting that activation of these nuclei results in increased energy expenditure (Cao, Fan, 
& Morison, 2004; Ceri, & Morison, 2005; DiMicco, & Zaretsky, 2006; Morison, & 
Nakamura, 2011; Zaretskaia, Zaretsky, Shekhar, & DiMicco, 2000). Additionaly, disruption 
of leptin receptors in the DMN blocked thermogenic responses to peripheral leptin, resulting 
in obesity (Dodd et al., 2014; Enriori et al., 2011). Conversely, however, lesions to the DMN 
or LHA resulted in hypophagia and reduced body weight, suggesting that the role of these 
nuclei in energy expenditure may be inhibitory rather than excitatory, and that multiple 
pathways are involved in regulating energy homeostasis; a phenomenon that wil be further 
discussed below (Belinger, & Bernardis, 2002; Yoshida, Kemnitz, & Bray, 1983).  
Other hypothalamic nuclei are also implicated in regulating energy homeostasis. 
Activation of the melanocortin system via injections of the synthetic agonist MTI into both 
the PVN and the VMN resulted in increased BAT temperatures via thermogenesis (Gavini, 
Jones, & Novak, 2016; Song et al., 2008). Additionaly, both hormonal and electrical 
stimulation of the PVN and the VMN resulted in decreased food intake, while loss of 
function of either in these nuclei (via functional disruptions by toxins, or electrolytic or 
chemical lesions) resulted in hyperphagia and increased body weight, leading to obesity 
(Choi, & Dalman, 1999; Leibowitz, Hammer, & Chang, 1981; Perkins et al., 1981; Resch et 
al., 2011; Resch et al., 2013; Sabatier, Leng, & Menzies, 2013). Both nuclei are, therefore, 
commonly associated with satiety and are known to be important nuclei for the regulation of 
energy metabolism (Perkins et al., 1981; Sabatier, Leng, & Menzies, 2013; Segal et al., 
2005).  
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In support of the literature that indicates PACAP is involved in the regulation of 
energy metabolism (detailed in Chapter 2), site-specific PACAP injections into the PVN and 
the VMN significantly decreased food intake, which was reversed with a PACAP receptor 
antagonist (Resch et al., 2013). Notably, however, PACAP injections into the VMN resulted 
in significantly increased core body temperature and spontaneous locomotor activity, 
whereas PVN injections of PACAP had no efect on energy expenditure (Resch et al., 2013). 
This suggests that despite similar regulation of energy intake upon PACAP stimulation in the 
PVN and VMN, these nuclei are diferentialy responsive to PACAP in terms of energy 
expenditure (Resch et al., 2013). Furthermore, in contrast to increased BAT temperatures 
observed in animals receiving injections of an MC4R agonist (MTI) in the PVN, the 
reintroduction of MC4R expression in the PVN of MC4R KO mice did not result in increased 
thermogenesis (Balthasar et al., 2005; Song et al., 2008). Notably, MC4R KO mice display a 
morbidly obese phenotype, resulting from increased appetite and decreased energy 
expenditure (Balthasar et al., 2005). The restoration of MC4R expression in the PVN of 
MC4R KO mice prevented 60% of the obesity, where the increased food intake was 
completely rescued, while the reduced energy expenditure was not (Balthasar et al., 2005; 
Madden, & Morison, 2008). This suggests that, similar to the diferential response to 
PACAP in the PVN and VMN discussed above, MC4Rs in the PVN control food intake 
while MC4Rs elsewhere control energy expenditure (Balthasar et al., 2005). Potentialy, this 
regulation of energy expenditure by MC4Rs may occur in the VMN, possibly under the 
regulation of PACAP (the focus of Chapter 2). 
While the VMN exhibits a major role in appetite regulation, it is also recognized for 
its role in energy expenditure, including thermogenesis, and continues to be a site of interest 
for body weight regulation (Choi et al., 2013; Lopez, & Tena-Sempere, 2017; Martinez de 
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Morentin et al., 2014; Perkins et al., 1981; Whitle et al., 2012). It contains numerous 
receptor types known to regulate energy metabolism, including high expression of leptin and 
PACAP receptors (Bingham et al., 2008; Dhilon et al., 2006; Hawke et al., 2009; Segal et 
al., 2005). As discussed in Chapter 1, leptin’s function in energy metabolism is not solely in 
appetite regulation in the ARC: leptin also regulates energy expenditure mainly via the VMN 
(Bingham et al., 2008). As such, when leptin receptors were knocked out in the VMN only, 
mice exhibited significantly increased adipose mass on a low-fat diet, and obesity on a high-
fat diet (Bingham et al., 2008). Leptin function is also connected to that of PACAP, whereby 
leptin-deficient mice exhibited significantly reduced PACAP mRNA levels that were 
restored with exogenous leptin treatments (Hawke et al., 2009). Additionaly, leptin acts by 
means of steroidogenic factor 1 (SF1), where leptin depolarization results in increased firing 
rate of SF1 neurons in the VMN (Dhilon et al., 2006; Hawke et al., 2009). The importance 
of SF1 in regulating gene expression in the VMN wil be discussed here. 
SF1 is a transcriptional factor required both for terminal diferentiation of the VMN 
as wel as energy metabolism processes (Choi et al., 2013). Notably, of al the genes 
expressed in the VMN, SF1 is the only gene that is specificaly and exclusively expressed in 
the VMN (Choi et al., 2013). SF1 expression also occurs in the pituitary gland, adrenal 
glands and the testes, but in no other brain region (Ikeda et al., 1995; Ingraham et al., 1994; 
Parker, & Schimmer, 1997). In SF1 KO animals, impaired development of the VMN ensued 
while other hypothalamic nuclei remained intact, ultimately resulting in high death rates 
likely atributable to adrenal insuficiency (Delovade et al., 2000; Ikeda et al., 1995; Luo, 
Ikeda, & Parker, 1994). To circumvent these deaths, healthy adrenal glands were transplanted 
into SF1 KO mice, resulting in a complete rescue of the adrenal phenotype while alowing 
for the analysis of predominantly VMN SF1 KO efects (Majdic et al., 2002). Interestingly, 
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adrenal-transplanted SF1 KO mice exhibited massive obesity compared to WTs, suggesting 
that the expression of SF1 in the VMN is critical in regulating body weight (Majdic et al., 
2002). However, the obese phenotype may have resulted as a consequence of the grossly 
impaired VMN structure, the inherent secondary efects from the transplantation or a 
combination of both, rather than the absence of SF1 signaling in the VMN. Therefore, mouse 
models were developed using the Cre transgene where SF1 was deleted postnataly to alow 
for proper development of the VMN and thus avoid confounding development side efects 
(Bingham, Verma-Kurvari, Parada, & Parker, 2006; Kim et al., 2011). Interestingly, these 
VMN specific SF1 KO animals continued to exhibit an obese phenotype, with impaired 
thermogenesis and decreased leptin receptor expression in the VMN (Kim et al., 2011). 
Colectively, these results provide compeling evidence that SF1 expression in the VMN is 
imperative for regulating energy homeostasis, including thermogenesis.  
Altogether, a considerable amount of evidence connects PACAP and the VMN in 
their essential roles in activating thermogenesis. The final piece of evidence to consider is the 
hypothalamic innervation to BAT, as this is the site of adaptive thermogenesis (Cannon, & 
Nedergaard, 2004). 
Neuronal pathways mediating hypothalamic regulation of adaptive thermogenesis in 
BAT have been elucidated with the use of retrograde viral tracers. When such viruses are 
injected into BAT, they infect and simultaneously label neurons (through expression of a 
molecular label) in a retrograde fashion, such that the entire eferent chain is labeled from the 
peripheral tissue to the brain regions from which the signal originated. Interestingly, 
retrograde viral tracing studies in BAT have shown connections to the PVN, LHA, DMN, 
and ARC, but not the VMN (Bamshad, Song, & Bartness, 1999; Bartness, Vaughn, & Song, 
2010; Oldfield et al., 2002; Ryu et al., 2015). Similarly, during short-term cold exposure 
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(four hours), viraly-infected neurons were observed in the PVN, LHA and DMN, but again, 
not the VMN (Cano et al., 2003). The conspicuous absence of viral tracing in the VMN is at 
odds with functional evidence discussed above that clearly demonstrates a role for the VMN 
in energy expenditure. This may be due to the limitations of viral tracing studies, which are 
generaly limited to three synaptic relays (Stefanidis, Wiedmann, Adler, & Oldfield, 2014). 
Therefore, if the VMN is the initial nuclei in which thermogenesis is activated, from which 
neurons project to other nuclei, the VMN may be beyond the extent of penetration of the 
retrograde viral tracers in the CNS. Alternatively, functional studies that implicate the VMN 
may actualy be involving nearby regions, resulting in compromised analysis. For example, 
chemical lesions of the VMN likely damages surounding regions, while microinjections into 
the VMN may result in leakage outside the targeted area (Choi et al., 2013). However, 
because SF1 is exclusively expressed in the VMN, the evidence discussed above for SF1’s, 
and thus the VMN’s, role in energy metabolism is indubitable (Bingham et al., 2008). 
Nevertheless, although complex and potentialy contrasting evidence exists for the 
hypothalamic regions regulating energy expenditure, the key players remain consistent and 
include leptin and the melanocortin system. Additionaly, we propose PACAP to be a key 
neurochemical regulator of energy metabolism in the VMN. 
Because maintenance of energy homeostasis is fundamental for life, it is likely that 
hypothalamic neurons overlap, communicating both directly and indirectly with each other 
and thus providing redundant processes to maintain energy homeostasis (Choi et al., 2013). 
As such, both PACAP and leptin innervation to nerve terminals in the PVN have been shown 
to originate in other hypothalamic nuclei, with major projections initiated in the VMN (Das, 
Vihlen, & Legradi, 2007; Elmquist et al., 1998). With immense research evidence 
considered, it is reasonable to suggest that hypothalamic signaling regulating BAT 
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thermogenesis likely includes multiple hypothalamic nuclei and that the complete networks 
of neural pathways involved remain to be elucidated. Given the functional evidence of the 
VMN’s role in thermogenesis, the high expression of PACAP in the VMN, the data from the 
PACAP KO mouse model that shows impaired thermogenesis in the absence of PACAP, and 
the evidence from pharmacological studies that show injections of PACAP in the VMN 
increases SNA to BAT, we conclude that the VMN is a logical and valid target to further 
elucidate PACAP’s role in thermogenesis.  
In order to target the VMN, limitations in the curent literature need to be overcome. 
Although intracerebroventricular and intrathecal injections of PACAP have resulted in 
increased BAT activity, these injections do not diferentiate between the hypothalamic 
regions specificaly involved in BAT activation, as injected PACAP likely spreads to to 
various surounding brain regions (Inglot, Farnham, & Pilowsky, 2011; Tanida et al., 2010). 
Additionaly, in diferentiating PACAP’s role in the PVN and VMN, Resch et al. (2013) 
provided results that were only colected over a 24-hour period. Therefore, in addition to 
replicating results to ensure accuracy, assessing the long-term function of PACAP in the 
VMN would expand the literature, particularly in elucidating PACAP’s role in activating 
adaptive thermogenesis during cold chalenges, as ful acclimation to cold and maximal 
induction of adaptive thermogenesis requires 3-4 weeks at 4°C (Cannon & Nedergaard, 2010; 
Meyer et al., 2010; Ukropec et al., 2006). As such, in future, an SF1-driven expression vector 
housing PACAP wil be introduced by viral delivery using stereotaxic injections directly into 
the VMN of PACAP KO mice to assess the efect of genetic reintroduction of PACAP 
specificaly in the VMN of animals lacking PACAP. The use of an adeno-associated virus 
serotype 9 (AAV9) wil alow for rapid onset of transduction of the brain tissues in the 
absence of immune responses, as wel as long term expression, and the use of a construct 
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where PACAP expression if driven by the SF1 promoter wil ensure PACAP is only 
expressed in VMN infected neurons that specificaly express SF1 (Daya, & Berns, 2008; 
Zincareli et al., 2008). Complete methodology wil be discussed below. 
Hypothesis and Aims 
I hypothesize that the cold sensitivity of PACAP -/- mice may be due to the absence 
of PACAP signaling within the VMN specificaly. 
Due to the complexity and long-term nature of this project, my involvement and thus the 
objectives of this chapter are: 
• To create an adenoviral construct that expresses GFP under the regulation of 
the SF1 promoter to act as a control vector, thus ensuring VMN-specific 
expression of the vector 
• Develop a protocol for stereotaxic injection of the vector which reaches the 
VMN in live animals 
Future directions wil be discussed in detail below (see 3.4 Discussion); however, to provide 
further understanding they are stated here: 
• To create an adenoviral construct for VMN-specific expression of PACAP to 
determine if the impaired thermogenesis in PACAP -/- mice can be geneticaly 
rescued by transgenic expression of PACAP in the VMN only, thus 
determining the importance of VMN PACAP in regulating thermogenesis	
3.2 MATERIALS AND METHODS 
AAV Plasmid Vector Backbone 
The self-complimentary (sc) pscAAV-GFP plasmid (Figure 3.1A) (created by John T. 
Gray, Addgene Plasmid #32396) was chosen as the expression vector backbone for large- 
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Figure 3.1. A. Plasmid map for pscAAV-GFP (Addgene Plasmid #32396). Image courtesy of John T. 
Gray. B. The CMV promoter within pscAAV-GFP was replaced with the SF1 promoter (pscAAV-
SF1-GFP) with the goal of expressing GFP specificaly in the VMN of the hypothalamus, a region of 
the brain known to specificaly express SF1. Virus wil be delivered to the brain via stereotaxic 
injection into the VMN. Adapted with permission from the author. Source:�
htps:/www.addgene.org/32396/. Accessed May 4, 2017. 
SF1 
A. 
B. 
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scale packaging and production of AAV9 aimed at transfecting cells in the VMN. To ensure 
specific VMN transfection, the ubiquitous promoter in pscAAV-GFP, cytomegalovirus 
(CMV), was replaced with the VMN-specific SF1 promoter (Figure 3.1B) from isolated 
mouse DNA prior to AAV9 packaging. To ensure adenoviral expression of GFP under the 
SF1 promoter upon stereotaxic injections in the VMN, the region of the SF1 gene chosen for 
isolation and amplification was 400 bp long with the inclusion of upstream transcription 
factor binding sites necessary for SF1 promoter function (Woodson, Crawford, Sadovsky, & 
Milbrandt, 1997). Detailed methodology is discussed below.  
Isolating the pscAAV-GFP Plasmid 
The pscAAV-GFP plasmid was purchased from Addgene and received packaged 
within Escherichia coli (E. coli) bacteria (transformed in Stbl2 competent cels) in an agar 
stab. Bacteria within the agar stab were streaked onto Luria broth (LB) agar plates containing 
ampicilin (Amp) (100µg/ml) (prepared according to Addgene protocol) and incubated 
overnight (18 hours) at 30°C, in accordance with the bacterial growth conditions. Three 
isolated single bacteria colonies were picked from the plates and each grown in 2ml of LB-
Amp liquid culture (prepared according to Addgene protocol) in a shaking incubator (300 
rpm) for 12 hours at 30°C, which served as starter cultures for scaled production of this low 
copy plasmid. A negative control that contained LB media and Amp without any bacteria 
was included in the above steps as an indicator of non-specific bacterial growth. Cels from 
each starter culture were peleted by centrifugation, resuspended in 1ml of fresh LB-Amp 
media and added to 100ml LB-Amp media, which served as a secondary culture. Only one 
starter culture resulted in peleted cels and was therefore used, while the other two were 
discarded. The secondary culture was placed in a shaking incubator (300 rpm) for 12 hours at 
30°C to alow for growth. Cels were peleted 6 x 1ml in 4 separate eppendorf tubes (1.5ml) 
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according to the manufacturer’s protocol for the QIAprep Spin Miniprep Kit (Qiagen, 
Hilden, Germany). Resuspension and lysis bufer (P1 and P2) volumes used were 1.6x those 
directed to ensure complete rinsing of the cels from the remaining LB media as wel as 
complete cel lysis. Neutralizing bufer (N3) was used at a volume 1.6x that directed by the 
manufacturer’s protocol and upon addition, tubes were inverted for 3 minutes to alow for 
complete DNA renaturation and precipitation of proteins and lipids. The optional wash step 
was used to remove endonucleases present in the bacteria strain (Stbl2). To increase yield, 
the eluted DNA from one eppendorf tube was used subsequently to elute the next in a 
sequential manner. Al other steps were folowed according to QIAprep Spin Miniprep Kit 
protocols (Qiagen, Hilden, Germany). DNA concentration and purity was assessed through 
UV light absorbance measurements using spectrophotometry (Nanodrop ND-1000; Thermo 
Scientific, Rockford, IL). As nucleotides absorb UV light at a wavelength of 260nm, 
absorbance levels of the sample at 260nm were used as a surogate measure of DNA 
concentration. The ratio of absorbance at 260nm and 280nm (the wavelength at which 
protein absorbs UV light) was used to assess the purity of DNA, where a ratio of ~1.8 is 
generaly accepted as “pure” for DNA. As a secondary measure of nucleic acid purity, the 
ratio of absorbance at 260nm and 230nm was used to identify the presence of contaminants 
that absorb at 230nm. 260/230 values commonly range between 2.0-2.2 for “pure” nucleic 
acid. To confirm integrity of the vector’s sequence (i.e. the absence of mutations or 
deletions), a diagnostic restriction digest was performed according to manufacturer’s 
protocols (New England BioLabs, Ipswich, Massachusets). The reaction included plasmid 
DNA (0.5µg), HindII and EcoRI (10 units of enzyme each), and New England BioLabs 
(NEB) Bufer 2.1. Digestion products were run on an ethidium bromide stained 1.5% agarose 
gel for 30 minutes at 100V and visualized under UV light. Expected band sizes were 3714 bp 
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and 655 bp. To further confirm the plasmid DNA was free of transcriptional erors 
sequencing, sequencing was performed using M13 Forward and Reverse primers (Applied 
Biosystems 3130x, UNBC Genetics Lab).  
Isolating the SF1 Promoter  
Methodology described in this section was completed in conjunction with an 
undergraduate honours thesis student (in colaboration with Aaron Germuth).  
SF1 DNA Extraction 
C57BL/6 WT mice were euthanized (110mg/kg euthanyl) and brains were colected 
and immediately placed in -80°C, ensuring rapid freezing. The hypothalamus was dissected 
from the frozen brain (~40mg), homogenized in TRIzol (Life Technologies), and DNA was 
isolated according to the manufacturer’s protocol. DNA concentration and purity were 
assessed by spectrophotometry as detailed above (Nanodrop ND-1000; Thermo Scientific, 
Rockford, IL).  
SF1 Primer Design and Amplification with PCR 
Primers were designed for PCR amplification of the 400 bp region of SF1 with at 
least 20 complimentary nucleotides. To facilitate future cloning, RE sites, matching those on 
either ends of the CMV promoter region within pscAAV-GFP, were added to each side end 
of the SF1 promoter region, with a 5 bp overhang to facilitate RE digestion. RE sites added 
were specific to AvrI (5’ CCT AAG 3’) and BspEI (5’ TCC GGA 3’). Care was taken to 
ensure similar GC content and melting points of the primers. PCR conditions were as 
folows: initial denaturation at 98°C (30 seconds), folowed by 35 cycles of denaturation 
(98°C for 10 seconds), annealing (67°C for 30 seconds), and extension (72°C for 30 
seconds). A final extension was performed at 72°C for 5 minutes. PCR products were run on 
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an ethidium bromide stained 1.5% agarose gel for 40 minutes at 100V and visualized under 
UV light with an expected band size of 400 bp. 
TA Cloning 
PCR-amplified SF1 was ligated into pGEM®-T Vector (Figure 3.2) using 2X Rapid 
Ligation Bufer and T4 DNA Ligase according to manufacturer’s protocol (Promega, 
Madison, WI), which alowed for blue-white screening selection. An aliquot of the ligation 
reaction (2.5µl) was added to 50µl of MAX Eficiency Stbl2 Competent Cels (Invitrogen, 
Carlsbad, CA) and plated on LB-Amp plates according to Addgene’s “Bacterial 
Transformation” protocols, and incubated overnight at 37°C. Resulting white colonies were 
picked into 10ml of LB-Amp media and incubated overnight at 37°C in a shaking incubator 
(225 rpm). Colony PCR for the SF1 promoter was performed on multiple colonies and 
successfuly cloned plasmids (as determined by bright 400 bp bands on the resulting PCR 
gel) were isolated using Wizard® Plus SV Minipreps DNA Purification System (Promega, 
Madison, WI). Glycerol stocks of the ligated SF1 fragment and pGEM®-T Vector (further 
refered to here as the SF1-pGEM®-T Vector) were created using overnight culture and 
glycerol according to Addgene protocols. Extracted plasmids were screened for corect 
placement of the SF1 promoter fragment by performing a double RE digest according to 
manufacturers protocols (Thermo Scientific, Rockford, IL). The reaction contained: plasmid 
DNA (1µg), AvrI and BspEI (10 units of enzyme each) and 1X Thermo Scientific Tango 
Bufer. Products were run on an ethidium bromide stained 1.5% agarose gel for 30 minutes at 
100V and visualized under UV light. Expected band sizes were 2600 bp and 400 bp. To 
further confirm the SF1-pGEM®-T plasmid was free of transcriptional erors, it was 
sequenced using T7 and SP6 primers (Applied Biosystems 3130x, UNBC Genetics Lab). 
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Figure 3.2. Plasmid map for pGEM®-T Vector (Promega). SF1 insert is ligated into the lacZ gene by 
ataching to overhanging thymine nucleotides, disrupting the lacZ gene. Accessed from 
htps:/www.promega.ca/products/pcr/pcr-cloning/pgem-t-vector-systems/. Copyright © 2017 
Promega Corporation. Image reproduced with permission from the corporation. 
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Replacing the CMV Promoter with the SF1 Promoter in the pscAAV-GFP Vector 
 The isolated pscAAV-GFP plasmid (15µg) and isolated SF1-pGEM®-T plasmid 
(5µg) were sent to Vigene Biosciences Inc. (Rockvile, MD) where SF1 was cloned into the 
pscAAV-GFP vector to replace the CMV promoter (Figure 3.1B) using AvrI and BspEI RE 
digestion and ligation reactions. The new plasmid was named pscAAV-SF1-GFP. 
Production of AAV9 Expressing pscAAV-SF1-GFP 
AAV9 packaging of the expression vector (pscAAV-SF1-GFP) and large-scale 
production of the virus AAV9-SF1-GFP was performed (concentration 2.24 x 1014 genome 
copy/ml) (Vigene Biosciences, Inc., Rockvile, MD). This virus wil be used as a control 
virus for this project, expressing GFP under the control of the SF1 promoter in specific brain 
regions infected with the virus through stereotaxic injections (described below). 
Devising a Stereotaxic Protocol for Injections into the VMN 
 Stereotaxic surgery is a new procedure in the Gray lab and therefore required training 
and development of experimental procedures. Stereotaxic workshops were held under the 
direction of Sheley McErlane (DVM), Senior Clinical Veterinarian and Head of Training for 
Animal Care Services at the University of British Columbia, and Lydia Troc (RVT and 
RLAT) from the University of Northern British Columbia, before performing surgeries 
independently. 
Positioning the Mouse in the Stereotaxic Frame 
Mice were weighed, anesthetized with sodium pentobarbital (90mg/kg, IP), and 
placed in a separate cage until a plane of anesthesia was reached, as observed by deep, 
regular breathing and no withdrawal upon a toe pinch. Fur was shaved from the surgical site, 
with care taken not to shave the whiskers, and disinfected with 70% alcohol. Eye lubricant 
was placed over the corneas of both eyes. Ear bars of the stereotaxic frame (Stoetling, Wood 
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Dale, Ilinois) were gently placed in the external auditory canal within the bula in both ears 
and tightened into place. Corect positioning was determined by smooth rotational movement 
of the snout up and down, with litle or no lateral movement. Ear bar measurements were 
consistent on each side such that the mouse was centered. Incisors were then placed over the 
incisor bar and the anesthetic cone was fited snuggly over the nose. Oxygen flow rate was 
kept at 0.8L/min while isoflurane was adjusted throughout to maintain a surgical level of 
anesthetic (normaly maintained at 2%). Throughout the procedure, the animal was placed on 
a heating pad controled by a thermometer placed in the rectum, measuring body temperature 
continuously and adjusting the heating pad temperature accordingly (Rodent Warmer, 
Stoetling, Wood Dale, Ilinois). A local anesthetic (bupivacaine, 2.5mg/ml; not exceeding 
8mg/kg) was injected subcutaneously along the planned incision site as a line block.  
Stereotaxic Surgery 
 Stereotaxic coordinates published for the VMN and used in this experiment were: -
1.46mm posterior from bregma, ± 0.39mm lateraly from midline and -5.50mm below the 
surface of the brain (Alen Institute for Brain Science, 2016). A stable plane of anesthesia 
was ensured prior to commencing surgery. An incision was then made such that lambda and 
bregma were exposed on the skul (Figure 3.3). The skin was gently puled back and the skul 
was cleaned using coton tipped applicators. A dril with a 1mm dril bit was atached to the 
stereotactic arm. The tip of the dril bit was positioned on lambda and the height was 
recorded. The tip of the dril bit was then positioned on bregma (Figure 3.4A) where the 
height was recorded again. The incisor bar was raised or lowered to level the skul such that 
the height of lambda and bregma were the same. The dril was moved in the posterior 
direction away from bregma 1.46mm, and to the right of the midline 0.39mm until the 
appropriate readings were aligned on the Vernier scale of the stereotaxic frame. At the 
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Figure 3.3. Location of lambda and bregma as defined by Dr. George Paxinos. Interaural line 
corresponds with the placement of the ear bars. Reproduced from “The rat brain in stereotaxic 
coordination”, by G. Paxinos, & C. Watson, 1998, 1st Edition, p. 11. Copyright © 2017 Academic 
Press/Elsevier. Reproduced with permission from publisher. 
 
 
 
 
 
 Figure 3.4. A. Stereotaxic administrations are given using x, y, and z coordinates to a specific 
location and depth. B. Location of injection into the VMN of the hypothalamus. Ilustrations by 
Encapsula NanoSciences LLC, Brentwood, TN. Copyright © 2014 Encapsula NanoSciences LLC. 
Obtained from htps:/www.clodrosome.com/animal-injection/. Adapted with permission from 
Encapsula NanoSciences.  
 
 
 
A. B. 
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intersection of these coordinates, in the X and Y plane, a hole in the skul was made by 
driling in smal increments such that the underlying brain was not damaged. The height of 
the top of the brain was then measured on the Vernier scale. The dril was replaced with a 
Hamilton syringe (70001KH, Hamilton Robotics, Switzerland) with a 25-gauge needle 
loaded with 1µl of 5x loading dye. From the surface of the brain, the needle was lowered 
5.50mm in the Z plane at a rate of 1mm/minute (Figure 3.4B). Dye was injected very slowly 
at a rate of 200nl/minute, and then the needle was left in place for 5 minutes to alow the 
fluid to be adsorbed before removing the needle it at a rate of 1mm/min. 
Post-Operative Procedure 
 Mice were euthanized with isoflurane and cervical dislocation. The brain was 
removed immediately and placed in 10% formalin for 24 hours. The fixed brain was 
dissected and the hypothalamus viewed under a stereo microscope (Olympus SXZ7) to 
visualize the location and to determine accuracy of the injection. Images were taken with an 
Infinity1 camera and Infinity Capture Software (Lumenera, Otawa, ON).  
3.3 RESULTS 
pscAAV-GFP Plasmid was Successfuly Isolated, Free of Transcription Errors 
To confirm that the bacteria containing the low-copy pscAAV-GFP plasmid had been 
grown up successfuly with no transcriptional erors, the plasmid DNA was sequenced using 
M13 Forward and Reverse primers. Using the National Center for Biotechnology 
Information’s (NCBI) Basic Local Alignment Search Tool (BLAST), sequencing results of 
the isolated pscAAV-GFP plasmid indicated matching nucleotide sequences to that of the 
purchased plasmid (Addgene Plasmid #32396), indicating no transcription erors (Figure 
3.5).  
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Figure 3.5. A section of nucleotides matching from NCBI’s BLAST between the pscAAV-GFP 
plasmid sequence provided from Addgene (Query) and the isolated plasmid (Sbjct) sequenced using 
M13 Reverse primer. Yelow indicates AvrII RE site (5’ CCT AGG 3’) and red indicates BspEI RE 
site (5’ TCC GGA 3’). A smal section of the isolated plasmid DNA was unreadable (indicated by 
“N”) using M13 Reverse primer. A matching sequence was confirmed using M13 Forward primer 
(results not shown). 
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SF1 was Successfuly Ligated with the pGEM®-T Vector 
 To confirm that SF1 was successfuly ligated into the pGEM®-T Vector with no 
transcriptional erors, bacterial plasmid DNA was sequenced using T7 and SP6 primers. 
Using NCBI’s BLAST, the DNA sequence of the ligated SF1-pGEM®-T Vector matched 
nucleotide sequences to that of Mus musculus strain C57BL/6J, chromosome 2, Genome 
Reference Consortium Mouse Reference 38 patch 4 (GRCm38.p4), which coresponds to the 
sequence of SF1 in the mouse genome (Figure 3.6).  
Stereotactic Injected-Dye was Localized in the Hypothalamus 
 To confirm the stereotaxic injection of the dye successfuly targeted the VMN of the 
hypothalamus, the brain was crudely cross-sectioned and visualized under a stereo 
microscope (Olympus SXZ7). Images showed blue dye visible in the third ventricle (3V) of 
the hypothalamus and surounding areas, including the VMN (Figure 3.7). However, dye 
appeared further dorsal in the hypothalamus than anticipated (Figure 3.7). The dye was not 
observed in any regions outside of the hypothalamus such as the basal forebrain (results not 
shown). 
3.4 DISCUSSION 
 Central and vital to this project was ensuring that the constructs for the VMN-specific 
adeno-associated viruses were properly designed and created such that future viral injections 
into the VMN via stereotaxic surgery wil prove safe and efective. The cloning strategy 
developed for this project utilized an expression vector caled pscAAV-GFP as a backbone. 
This vector can be packaged in an adeno-associated virus serotype 9, such that infected cels 
express GFP under control of the CMV promoter. Because the CMV promoter would drive 
gene expression in al brain tissues, CMV was replaced with SF1, which when injected into 
the brain wil drive gene expression in cels of the VMN only. Using the SF1 gene region that 
 111 
�Figure 3.6. NCBI’s BLAST search of the sequence obtained from SF1-pGEM®-T Vector (Sbjct) 
using T7 primer revealed a match to a section of the Mus musculus strain C57BL/6J, chromosome 2, 
GRCm38.p4 (Query): the region of the mouse genome that houses the SF1 promoter. Yelow 
indicates AvrII RE site (5’ CCT AGG 3’) and red indicates BspEI RE site (5’ TCC GGA 3’) added to 
the PCR-amplified SF1. 
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Figure 3.7. A. Coronal cross section of the brain showing the location of the hypothalamus and close-
up five key hypothalamic nuclei involved in the regulation of energy metabolism. PVN; 
paraventricular nucleus, DMN; dorsomedial nucleus, LHA; lateral hypothalamic area, VMN; 
ventromedial nucleus, ARC; arcuate nucleus, 3V; third ventricle. Adapted from “Revisiting the 
Ventral Medial Nucleus of the Hypothalamus: The Roles of SF-1 Neurons in Energy Homeostasis”, 
by Y. Choi, T. Fujikawa, J. Lee, A. Reuter, & K. Kim, 2013, Frontiers In Neuroscience, 7. Copyright 
© 2013 Choi, Fujikawa, Lee, Reuter and Kim. Adapted with permission from author. B. Dorsal view 
of the mouse brain. C. Ventral view of the mouse brain (box indicates hypothalamus). D. Blue dye 
observed in the hypothalamus. E. Anterior coronal section through the hypothalamus; blue dye 
observed in the 3V and surrounding hypothalamic tissues. F. Middle coronal section through the 
hypothalamus; dye localized along the 3V. G. Posterior coronal section through the hypothalamus; 
dye localized further dorsal along the 3V.  
�
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�
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�
�
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�
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included al necessary transcription factors for SF1 promoter activity wil alow for the 
expression of GFP (control) or PACAP, specificaly in the VMN of AAV9-injected mice. In 
order to provide Vigene with the components required to generate AAV9 expressing the 
control plasmid (AAV9-SF1-GFP), the pscAAV-GFP and SF1-pGEM®-T vectors were 
produced and Vigene successfuly cloned SF1 into the pscAAV-GFP vector and packaged 
this construct into AAV9 such that we have the AAV9-SF1-GFP control virus to test VMN 
specific gene delivery. 
Prior to commencing stereotaxic injections with the control virus expressing GFP 
(AAV9-SF1-GFP), we instead injected dye containing bromophenol blue to visualize if the 
published VMN coordinates (anterior/posterior -1.46mm from bregma; medial/lateral, ± 
0.39 mm from midline; and dorsal/ventral, -5.50mm from surface of the brain (Alen Institute 
for Brain Science, 2016) were in fact alowing targeted delivery to the VMN. From the 
observed formalin-fixed hypothalamic sections, dye was observed superior to the anticipated 
location and therefore is potentialy not reaching the VMN (Figure 3.7). We thus conclude 
that the coordinate for the Z-plane is lower than -5.50mm from the surface of the brain, and 
future injections wil use the coordinate of -5.70mm from the surface of the brain in hopes of 
achieving injections closer to the base of the hypothalamus, specificaly in the VMN. This 
change may appear conservative (Δ0.2mm), but precision in the hypothalamus is imperative 
as the distance between the top and botom of the 3V is only 1mm (Figure 3.8).  
 Although the goal of the stereotaxic injections is to reach the VMN as this would 
result in the greatest infection of target cels, injections into the 3V is also an option as our 
expression vector is driven by the SF1 promoter which is exclusively expressed in the VMN 
(Choi et al., 2013). Therefore, if injections were made into the 3V (a larger target than the 
VMN) or not entirely in the VMN, we can be confident that GFP, and in future PACAP, wil  
 114 
	 
Figure 3.8. Middle coronal cross section through the hypothalamus of Mus musculus stereotaxicaly 
injected with 5x loading dye. Ruler shows 1mm increments. 
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only be expressed in the VMN. Additional injections wil be conducted to ensure location 
accuracy prior to commencing experiments using the control virus. 
Future Directions 
 Performing a genetic intervention to assess if the impaired thermogenic capacity 
observed in PACAP KO can be rescued with VMN-specific injections of PACAP is both a 
complex and long-term project in the Gray lab. As part of this thesis, preliminary work has 
been completed such that the project may progress. Here, an adenoviral construct that 
expresses GFP under the regulation of the SF1 promoter has been created, and a stereotaxic 
protocol for the injection of this virus has been developed. The remainder of this project wil 
be completed by the Gray lab. 
The long-term aim of this project is to geneticaly reintroduce PACAP in PACAP KO 
mice in the neurons of the VMN only, and assess if the impaired thermogenesis is improved 
(or rescued). To do so, the control virus discussed above (AAV9-SF1-GFP) wil be used for 
two reasons: firstly, to confirm the eficacy of the ICV-VMN injections, and secondly, to 
behave as a control for comparisons between mice injected with the experimental virus 
(AAV9-SF1-PACAP) (discussed below).  
 To determine eficacy of the ICV-VMN injections, AAV9-SF1-GFP injected animal 
brains wil be sectioned, and the location of GFP wil be assessed using an established 
immunohistochemistry protocol in the Gray lab, where a primary antibody binds to GFP, 
folowed by secondary antibody binding to amplify the signal such that the location of GFP 
expression can be visualized under a fluorescent microscope. Once the location of GFP 
expression is determined in the VMN, experimental injections may commence. First, 
however, construction of the experimental virus, AAV9-SF1-PACAP is required, where 
PACAP wil replace GFP in the control virus, AAV9-SF1-GFP. 
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 The pscAAV-SF1-GFP expression vector wil be used for construction of the 
experimental virus. PCR amplification of PACAP from hypothalamic cDNA wil be ligated 
with the pGEM®-T Vector (Figure 3.2) and sent to Vigene, along with isolated pscAAV-
SF1-GFP plasmid where PACAP wil replace GFP (Figure 3.9), and large-scale AAV9 
packaging of the expression vector wil be produced. This virus wil be named: AAV9-SF1-
PACAP. 
To assess whether the cold sensitivity of PACAP -/- mice is due to the absence of 
PACAP signaling within the VMN specificaly, physiological and biochemical assessments 
of thermogenic markers similar to those in Chapter 2 wil be used to determine if the PACAP 
-/- phenotype can be rescued with genetic reinsertion of PACAP in the VMN. Therefore, 
aseptic surgical technique wil be performed in order to avoid infection, and animals wil be 
recovered post-surgery to alow for viral transfection of cels in the VMN as wel as for cold 
acclimation prior to thermogenic assessments. 
In conclusion, further elucidation of the complex pathways associated with PACAP in 
the VMN and their roles in regulating adaptive thermogenesis wil contribute to the pool of 
knowledge available for pathways controling energy expenditure. Because energy 
expenditure contributes immensely to whole body energy homeostasis, this knowledge may 
contribute to the development of safe and efective therapies for metabolic disorders, 
including obesity, and wil be further discussed in Chapter 4. 
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Figure 3.9. The CMV promoter replaced with the SF1 promoter, and the GFP gene replaced with the 
PACAP gene (pscAAV-SF1-PACAP) with the goal of expressing PACAP specificaly in the VMN of 
the hypothalamus, a region of the brain known to specificaly express SF1. Virus wil be delivered to 
the brain via stereotaxic injection into the VMN. Adapted with permission from the author. Source:�
htps:/www.addgene.org/32396/. Accessed May 4, 2017. 
 
 
 
 
 
 
 
 
 
 
SF1 
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CHAPTER 4 
Concluding Remarks for PACAP’s Role in the Ventromedial Nucleus and its 
Association with the Melanocortin System in Regulating Adaptive Thermogenesis 
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4.1 SUMMARY 
The work presented in this thesis was completed to address the hypothesis that:  
(A) PACAP acts upstream from the melanocortin system to regulate SNA to stimulate 
adaptive thermogenesis in BAT (Chapter 2) (Figure 4.1), and (B) that the cold sensitivity of 
PACAP -/- mice may be due to the absence of PACAP signaling within the VMN 
specificaly (Chapter 3) (Figure 4.1). 
The objectives of this research were: 
1. To determine if the impaired thermogenesis in PACAP -/- mice could be 
rescued pharmacologicaly with a melanocortin agonist, Melanotan I (MTI), 
and thus provide evidence using a genetic model of PACAP deficiency for the 
connection between PACAP and the melanocortin system in regulating 
thermogenesis in BAT 
2. To create an adenoviral construct that expresses GFP under the regulation of 
the SF1 promoter to act as a control vector to be used in stereotaxic surgery, 
thus ensuring VMN-specific expression of the vector  
3. To devise a protocol for stereotaxic injections that reached the VMN in live 
animals 
Objectives 2 and 3 were devised as preliminary steps for the folowing future objective: 
4. To create an adenoviral construct for VMN-specific expression of PACAP to 
determine if the impaired thermogenesis in PACAP -/- mice can be geneticaly 
rescued by transgenic expression of PACAP in the VMN only, thus 
determining the importance of VMN PACAP in regulating thermogenesis 
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Figure 4.1. Hypothesized pathways of interaction for adaptive thermogenesis in BAT in response to 
cold exposure. VMN; ventromedial nucleus, PACAP; pituitary adenylate cyclase-activating 
polypeptide, MC; melanocortin system, SNA; sympathetic nerve activity, BAT; brown adipose tissue. 
Images adapted from “Revisiting the Ventral Medial Nucleus of the Hypothalamus: The Roles of SF-
1 Neurons in Energy Homeostasis”, by Y. Choi, T. Fujikawa, J. Lee, A. Reuter, & K. Kim, 2013, 
Frontiers In Neuroscience, 7. Copyright © 2013 Choi, Fujikawa, Lee, Reuter and Kim. Adapted with 
permission from author. 
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Chapter 2 addressed the hypothesis and research aim 1 through the evaluation of 
thermogenic capacity of cold-acclimated MTI treated PACAP -/- mice, using physiological 
(body weight and composition, metabolic rate (open circuit calorimetry), and respiratory 
exchange ratio (RER), molecular (thermogenic gene expression), and histological (lipid area 
and cel count) analyses. Results indicate that through activation of the melanocortin system 
with peripheral injections of the MC4R agonist MTI, the impaired thermogenesis of cold-
acclimated PACAP -/- mice was partialy rescued. This finding provides preliminary 
evidence to support the hypothesis that PACAP acts upstream from the melanocortin system 
in regulating SNA to BAT to induce adaptive thermogenesis during cold exposure. This 
preliminary evidence supports the available, but limited, literature with the use of a genetic 
model of PACAP -/- mice and therefore adds significant value to the curent pool of research. 
Future analyses wil help support or refute the partial physiological rescue of adaptive 
thermogenesis with MTI treatment of cold-acclimated PACAP -/- mice and wil include: 
increasing sample size to more robustly measure gene and protein expression of thermogenic 
proteins in BAT, ingWAT, and gWAT depots, and performing further histological analyses 
of adipose tissues to identify characteristics of thermogenicaly active adipose tissue (such as 
measuring lipid content and browning in ingWAT and gWAT depots).  
Chapter 3 addressed the hypothesis through research aim 2 and 3, which were vital 
preliminary steps for the future research aim 4. Aim 2 ensured that the constructs for the 
VMN-specific adeno-associated viruses were properly designed and created such that future 
viral injections into the VMN via stereotaxic surgery wil prove safe and efective. Aim 3 
further ensured safe and efective stereotaxic surgery through the development of appropriate 
stereotaxic injection protocols. Protocols were devised through the atendance of stereotaxic 
surgery workshops, as wel as through visualization of the brain post-injections to 
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preliminarily assess the eficacy of the ICV-VMN injections. The overarching future aim of 
this project is to geneticaly reintroduce PACAP in PACAP -/- mice in neurons of the VMN 
only, and assess if the impaired thermogenesis is improved (or rescued). Changes in 
thermogenic capacity wil be measured via physiological and biochemical assessments of 
thermogenic markers used in Chapter 2. 
4.2 SIGNIFICANCE 
Obesity is both a debilitating disease as wel as a risk factor for a number of other 
chronic metabolic diseases; the consequences of which range from decreased quality of life 
to premature death (Lidel, Betz, & Enerbäck, 2014; WHO, 2016). Repercussions of the 
disease are high, both at the individual level with patient sufering, as wel as the societal 
level with increased economic burden (Lidel et al., 2014, Uzogara, 2017). To provide 
appropriate prevention and management for this disease, the mechanisms of action resulting 
in the disease must initialy be understood. With obesity, the disrupted mechanism in 
question is energy homeostasis, controled both by energy intake and energy expenditure 
(Farooqi & O’Rahily, 2006; Hinney, Vogel, & Hebebrand, 2010). Despite lifestyle 
interventions that suggest decreasing food intake and increasing physical activity, the 
prevalence of adult obesity continues to rise (Galic et al., 2010; WHO, 2016) Therefore, it 
has become evident that further exploration into the pathophysiology of the disease is 
necessary to prevent and manage this disease efectively (Galic et al., 2010; WHO, 2016). 
Here, the research was focused on energy expenditure, which is comprised of many systems 
and mechanisms, one of which is adaptive thermogenesis in BAT (Blondin et al., 2014; 
Lidel et al., 2014; Peirce et al., 2014). The greatest physiological stimulus regulating 
adaptive thermogenesis is via SNA where the release of NE acts directly at the level of 
brown adipocytes to generate heat in the body via the thermogenic protein, UCP1 (Lidel et 
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al., 2014; Peirce et al., 2014; Saito, Yoneshiro, & Matsushita, 2016). Furthermore, as 
proposed in this thesis, it is hypothesized that PACAP and the melanocortin system act in the 
VMN to regulate SNA that drives adaptive thermogenesis (Diané et al., 2014; Gray et al., 
2002; Tanida, Shintani, & Hashimoto, 2011). Ultimately, understanding the role of PACAP 
in the VMN and its association with the melanocortin system in regulating SNA to stimulate 
adaptive thermogenesis in BAT wil provide further knowledge regarding one of the many 
pathways regulating energy expenditure. Because metabolic diseases, including obesity, are 
examples of dysregulated energy homeostasis, determining how and where normal 
physiology goes awry (pathophysiology) wil potentialy provide therapeutic targets to help 
corect these detrimental diseases, either through lifestyle interventions, pharmacological 
interventions, or both. 
 For example, because activation of the sympathetic nervous system (SNS) has been 
shown to increase BAT activation and thermogenesis, anti-obesity pharmaceuticals such as 
sibutramine and ephedra were developed to stimulate the SNS (Saito, Yoneshiro, & 
Matsushita, 2016). However, research has shown that activating the SNS alone through the 
use of these pharmaceuticals is not an appropriate option for weight loss, as they are known 
to cause undesirable and dangerous side efects including hepatotoxicity, cardiovascular 
complications, and sudden death (Yen, & Ewald, 2012). As such, further research into 
particular mechanisms of energy metabolism wil alow for the optimization of the 
thermogenic capacity of BAT without side efects derived with SNS activation. Potentialy, 
this may be through selective stimulation of the SNS to BAT, other modes of BAT activation 
beyond the SNS, or other avenues of energy homeostasis altogether. Altogether, 
understanding the biological mechanisms that contribute to the health crisis of obesity is 
critical in developing interventions to reduce its prevalence.  
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Lastly, regardless as to whether appropriate lifestyle interventions or therapeutic 
targets are derived from this area of research, there is stil an absolutely clear benefit: that is, 
providing evidence that the disease of obesity involves more than simply increasing one’s 
self-control, eating less, and exercising more. Helping to eliminate this stigma by providing 
physiological evidence that energy metabolism is deeply seeded in hormonal control through 
the body’s metabolic systems is an incontrovertible advancement resulting from this area of 
research. 
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